Bone Loss, Perimenopausal

Synonym
Postmenopausal Bone Loss
Bone Loss, Postmenopausal
Osteoporosis, Post-Menopausal
Bone Loss, Perimenopausal
Postmenopausal Osteoporosis
Perimenopausal Bone Loss

Excerpt	Reference
"Prevention of postmenopausal osteoporosis is now possible with current therapy, if initiated soon after the menopause and continued for at least 10 years."	( Edwards, AC; McGarrigle, HH; Perry, LA; Spector, TD; Thompson, PW, 1991)
"The postmenopausal bone loss is related to serum GH, E2 levels."	( Li, G; Zeng, M, 1990)
"Prevention of postmenopausal osteoporosis is an alternative to the currently problematic goal of reversing the trabecular plate thinning and perforation that constitute the major pathologic defects in patients with established osteoporosis."	( Drezner, MK; Nesbitt, T, 1990)
"Postmenopausal osteoporosis is a burden both to the society and to its victims."	( Nagant de Deuxchaisnes, C, 1989)
"Postmenopausal osteoporosis is a serious health problem, and additional treatments are needed."	( Bell, NH; Bröll, J; Dequeker, J; Downs, RW; Favus, M; Liberman, UA; Minne, HW; Quan, H; Rodriguez-Portales, J; Weiss, SR, 1995)
"Postmenopausal osteoporosis is not a well-defined disease, but summarizes women with different severity of changes in bone metabolism and different clinical complaints."	( Leidig-Bruckner, G; Ziegler, R, 1994)
"Postmenopausal osteoporosis is a major health problem."	( Sicouri, R, 1993)
"Postmenopausal osteoporosis is a major health care problem that affects 20 million women in the United States and accounts for > 1 million fractures per year."	( DeCherney, A, 1996)
"Postmenopausal bone loss is associated with a rise in the fasting urine calcium excretion which has been proposed to be a possible cause of increased bone resorption."	( Mason, RA; Morris, HA; O'Loughlin, PD; Schulz, SR, 1995)
"The features of postmenopausal bone loss are consistent with the etiology of the condition being primarily withdrawal of estrogen's contribution to bone's mechanically adaptive response."	( Lanyon, LE, 1996)
"Postmenopausal osteoporosis is linked clearly to estrogen deprivation."	( Notelovitz, M, 1997)
"The postmenopausal osteoporosis is mainly caused by estrogen deficiency and hormone replacement therapy (HRT) has been shown to prevent the progress of osteoporosis."	( von Holst, T, 2000)
"Postmenopausal bone loss is the major determinant of osteoporosis."	( Ciaponi, M; Gambacciani, M, 2000)
"Postmenopausal osteoporosis is a widespread condition that affects the physical and emotional well-being of millions of women worldwide."	( Watts, NB, 2001)
"A case review of postmenopausal osteoporosis is presented in the context of recent literature in the field."	( Elliott, ME, 2002)
"Postmenopausal osteoporosis is a complex and heterogeneous disease influenced by multiple factors and related to peak bone mass achieved in early adult life, followed by a subsequent continuous bone loss."	( Bollerslev, J; Devine, A; Dhaliwal, SS; Dick, IM; Prince, RL; Wilson, SG, 2004)
"The therapy of postmenopausal osteoporosis is based on a few comprehensible assumptions."	( Keck, E, 2003)
"Postmenopausal osteoporosis is a major public health problem."	( Gambacciani, M; Vacca, F, 2004)
"The main cause of postmenopausal osteoporosis is estrogen deficiency and it was revealed that the continuous combined use of conjugated estrogen and medroxyprogesterone acetate reduced the relative risk of femoral neck fracture to 0."	( Nozaki, M, 2006)
"Postmenopausal osteoporosis is the result of estrogen deficiency, which results in up-regulation of several cytokines and excessive bone resorption."	( Kamel, HK, 2006)
"Postmenopausal osteoporosis is the result of estrogen deficiency and excessive bone resorption."	( Kamel, HK, 2006)
"Postmenopausal osteoporosis is a serious, chronic condition, for which nitrogen-containing bisphosphonates are now one of the treatments of choice."	( Bruyère, O; Neuprez, A; Reginster, JY, 2008)
"Postmenopausal osteoporosis is a chronic disease, which justifies long-term treatment in those women with an increased risk of fracture."	( Pouilles, JM; Ribot, C; Trémollieres, F, 2009)
"Postmenopausal osteoporosis is common and is associated with stooped posture, loss of height, back pain and fractures."	( Doggrell, SA, 2009)
"Postmenopausal osteoporosis is an increasing worldwide health concern affecting an estimated 200 million individuals."	( Chines, AA; Komm, BS, 2009)
"Postmenopausal osteoporosis is an asymptomatic skeletal disease that is often underdiagnosed and undertreated."	( Lewiecki, EM, 2009)
"Postmenopausal osteoporosis is a chronic condition due to decreased bone mass, leading to reduced bone strength and increased fracture risk."	( Doherty, JG; Ringe, JD, 2010)
"Postmenopausal osteoporosis is mainly treated with estrogen replacement therapy (ERT)."	( Mohamed, N; Muhammad, N; Ping, LL; Shuid, AN; Soelaiman, IN, 2011)
"Postmenopausal osteoporosis is complicated with vertebral, femoral or radius fracture."	( Alam, M; Asaduzzamnan, AK; Chowdhury, IH; Emran, MA; Ferdous, C; Habib, AH; Hossain, M, 2010)
"Postmenopausal osteoporosis is a disease of high bone remodeling, with an imbalance of bone resorption over bone formation, resulting in decreased bone mineral density and disruption of bone microarchitecture."	( Lewiecki, EM, 2011)
"Postmenopausal osteoporosis is a chronic disease requiring treatment that balances long-term fracture efficacy against risk."	( Cooper, C; Cortet, B; Diaz-Curiel, M; Kanis, JA; Lorenc, RS; Reginster, JY; Rizzoli, R, 2012)
"Postmenopausal osteoporosis is recognized as a cytokine driven disease, but the mechanism that how estrogen deficiency interplaying with cytokines to stimulate bone loss remains to be elucidated."	( Zhao, R, 2012)
"Postmenopausal osteoporosis is now a major health problem."	( Rodríguez Rodríguez, LP, 2011)
"Postmenopausal osteoporosis is a chronic disease that exerts a significant burden on both individuals and the community."	( Bruyère, O; Pelousse, F; Reginster, JY, 2013)
"Postmenopausal osteoporosis is caused by estrogen deficiency."	( Imai, Y, 2013)
"Postmenopausal osteoporosis is one of the most common disorders in women after menopause, which is linked to an estrogen deficiency and characterized by an excessive loss of trabecular bone."	( Chan Kang, S; Jang, SA; Jung Koo, H; Kim, YJ; Namkoong, S; Sohn, EH, 2014)
"Postmenopausal osteoporosis is a silent systemic progressive disease characterised by a decrease in bone mass per unit volume."	( Borg, M; Brincat, SD; Calleja-Agius, J; Camilleri, G, 2014)
"Postmenopausal osteoporosis is now hypothetically considered to be an autoimmune and inflammatory process in which many pro-inflammatory and T cell-derived cytokines play important roles in the loss of bone mass."	( Fu, Q; Ren, Z; Shen, T; Wang, C; Wang, G; Wang, Y; Wu, L; Zhang, J, 2015)
"Postmenopausal osteoporosis is a worldwide health problem and is characterized by increased and activated osteoclasts."	( Du, J; Gao, B; Guo, K; Huang, Q; Jie, Q; Li, X; Li, Y; Lin, Y; Liu, J; Luo, Z; Shi, J; Wang, C; Wang, L; Yang, L; Zhang, H; Zhao, Y, 2016)
"Postmenopausal osteoporosis is an important metabolic bone disease characterized by rapid bone loss occurring in the postmenopausal period."	( Al-Badr, FBM; Al-Daghri, NM; Al-Saleh, Y; Aljohani, NJ; Amer, OE; Aziz, I; Sheshah, E; Yakout, S; Younis, GZ, 2017)
"Postmenopausal osteoporosis is often treated with bisphosphonates (eg, alendronate, [ALN]), but oversuppression of bone turnover by long-term bisphosphonate treatment may decrease bone tissue heterogeneity."	( Altman-Singles, AR; de Bakker, CM; Han, L; Jeong, Y; Kim, DG; Liu, XS; Lott, C; Qin, L; Robberts, J; Tseng, WJ; Zhao, H, 2017)
"Postmenopausal osteoporosis is a frequent cause of morbidity and can negatively impact life expectancy; iodine is an essential element for bone mineralization, and iodine deficiency is frequently observed."	( Arslanca, SB; Arslanca, T; Ergün, Y; Karadag, B; Korkmaz, V, 2018)
"Postmenopausal osteoporosis is becoming an urgent health problem in China."	( Wang, H; Xiang, C; Xiao, X; Xu, W; Yuan, H; Zhao, X, 2018)
"Postmenopausal osteoporosis is a highly prevalent disease."	( Cano, A; Chedraui, P; Goulis, DG; Lambrinoudaki, I; Lopes, P; Mishra, G; Mueck, A; Rees, M; Senturk, LM; Simoncini, T; Stevenson, JC; Stute, P; Tuomikoski, P, 2018)
"Even if postmenopausal osteoporosis is accompanied by diabetes in this animal model, both alendronate and raloxifene seem to show antiresorptive effects, decreased bone turnover rates, and improved bone mechanical strength."	( Cho, DC; Gupta, R; Han, I; Kim, CH; Kim, KT; Kwon, JT; Lee, YS; Park, EK; Seo, YJ; Seu, SY; Sung, JK, 2018)
"Postmenopausal osteoporosis is a bone metabolism disease that is caused by an imbalance between bone-resorbing osteoclast and bone-forming osteoblast actions."	( Hong, JQ; Hu, B; Jiang, GY; Li, SH; Ma, CY; Meng, JH; Teng, WS; Wang, C; Yan, SG; Yang, YT; Zhao, CC; Zhou, CH, 2018)
"Postmenopausal osteoporosis is the most common form of primary osteoporosis, and the incidence of the condition is rapidly increasing."	( Han, W; Jia, Y; Jiang, J; Lu, X; Pang, C; Peng, J; Qian, Y; Zhang, T; Zhao, K; Zhu, J, 2019)
"Postmenopausal osteoporosis is characterised by increased bone turnover and an imbalance between bone resorption and formation."	( Eastell, R; Gossiel, F; McCloskey, EV; Naylor, KE; Paggiosi, MA; Peel, N; Walsh, J, 2020)
"Postmenopausal osteoporosis is one of the most common types of osteoporosis resulting from estrogen deficiency in elderly women."	( Huo, S; Li, H; Nie, B; Qu, X; Tang, H; Yue, B; Zhang, S, 2020)
"Postmenopausal osteoporosis is one of the most common types of osteoporosis resulting from estrogen deficiency in elderly women."	( Huo, S; Li, H; Nie, B; Qu, X; Tang, H; Yue, B; Zhang, S, 2020)
"Postmenopausal osteoporosis is associated with body weight and fat mass gain, and the aim of the present study was to evaluate the effect of consuming enriched pumpkin on the levels of adipokines and cytokines produced by the adipose tissue."	( Gramza-Michałowska, A; Kołodziejski, P; Kulczyński, B; Kurzawa, P; Suliburska, J; Wawrzyniak, N, 2021)
"Postmenopausal osteoporosis is characterized by an imbalance of bone resorption exceeding bone formation, resulting in a net loss of bone mass."	( Liu, GW; Liu, H; Liu, LL; Xu, YJ; Zhao, K, 2021)
"Postmenopausal osteoporosis is a type of chronic disease with high morbidity and high economic burden."	( Dong, B; Gong, S; Lang, S; Ma, J; Ma, X; Wang, Y, 2022)
"Postmenopausal osteoporosis is a kind of degenerative disease, also described as "invisible killer."	( Cai, H; He, W; Zhang, H, 2023)
"Postmenopausal osteoporosis is the most common type of osteoporosis."	( Han, B; Han, J; Jiang, Z; Peng, Y; Sun, X; Zhang, W, 2023)
"Postmenopausal osteoporosis is a common bone metabolic disease, and gut microbiota (GM) imbalance plays an important role in the development of metabolic bone disease."	( Guan, Z; Jia, J; Jiang, C; Leng, H; Song, C; Sun, T; Xu, Y; Xuanqi, Z; Yuan, W; Zhang, C; Zhu, J, 2023)

Excerpt	Reference
"Postmenopausal osteoporosis has long-term physical, psychological, and social consequences with a major impact on patients' daily life."	( Delmas, PD, 2005)
"Postmenopausal osteoporosis has a big impact on health care expenses, with associated spending expected to double for osteoporosis by the year 2050."	( Gosch, M; Kammerlander, C; Nicholas, JA, 2014)
"Pathophysiology of postmenopausal osteoporosis has been considered due to deficiency of estrogen."	( Imai, Y, 2014)
"Postmenopausal osteoporosis has been linked to accelerated cognitive decline; however, little is known about the effects of medical treatment on cognitive functions."	( Demir, SO; Safer, U; Safer, VB; Yanikoglu, I, 2016)
"Postmenopausal osteoporosis has seriously affected the life quality of elderly women."	( Han, B; Jiang, Z; Li, Z; Liu, W; Peng, Y; Yang, Y; Zhang, W, 2018)

Excerpt	Reference
"Postmenopausal osteoporosis affects 7-10% of the population of developed countries."	( Lakatos, P, 2008)
"Postmenopausal osteoporosis affects millions of women, being estrogen deficiency the key factor in the pathogenesis of involutional osteoporosis."	( Gambacciani, M; Levancini, M, 2014)

Excerpt	Reference
"An animal model of postmenopausal osteoporosis was established and the animals were treated with sex hormones in the experiment."	( Han, ZH, 1992)
"Thirty-six women with postmenopausal osteoporosis (31 of them with at least one non-traumatic vertebral compression fracture) were matched pair-wise as to age, years since menopause and body mass index and randomized to receive either cyclical estrogen-progestagen replacement treatment (group 1) or the same treatment plus nandrolone decanoate (group 2)."	( Birkenhäger, JC; Birkenhäger-Frenkel, DH; Erdtsieck, RJ; Gerritsma, EJ; Kooy, PP; Luiken, GP; Mulder, P; van Kuik, C; van Veen, LC; Zeelenberg, J, 1992)
"Continuous treatment of postmenopausal osteoporosis with calcitriol for three years is safe and significantly reduces the rate of new vertebral fractures in women with this disorder."	( Dovey, S; Spears, GF; Thomson, J; Tilyard, MW, 1992)
"Nineteen patients with postmenopausal osteoporosis were treated with 200 u (15 nmol) synthetic salmon calcitonin (sCT) intranasally per day for 15 months."	( Dambacher, MA; Fischer, JA; Muff, R, 1991)
"Forty seven women with postmenopausal osteoporosis and at least one but no more than four vertebral compression fractures received sequential and cyclical therapy with phosphorus and etidronate (p/etid)."	( Anger, MS; Kowalski, L; McIntyre, DO; Miller, PD; Neal, BJ; Yanover, MJ, 1991)
"Prevention of postmenopausal osteoporosis is now possible with current therapy, if initiated soon after the menopause and continued for at least 10 years."	( Edwards, AC; McGarrigle, HH; Perry, LA; Spector, TD; Thompson, PW, 1991)
"Prophylactic treatment of postmenopausal osteoporosis with oestrogen and calcium, often in combination, disregards the likelihood that an excess of each agent may increase magnesium requirements and decrease serum Mg levels."	( Seelig, MS, 1990)
"We report on 61 women with postmenopausal osteoporosis who were treated with either plain sodium fluoride (NaF) capsules or enteric-coated NaF tablets for 4 years, in whom possible therapeutic and toxic effects were monitored."	( Bayley, TA; Budden, F; Chow, R; Harrison, JE; Josse, RG; Kandel, R; Laurier, L; Murray, TM; Pritzker, KP; Sturtridge, WC, 1990)
"This accelerated phase of postmenopausal bone loss can be prevented by estrogen substitution therapy."	( Boonen, S, 1995)
"We conclude that treatment of postmenopausal osteoporosis with oestrogen/progestogen for 3 years results in net spinal bone gain and a positive effect on calcium balance slightly better than that of intermittent etidronate."	( Charles, P; Hasling, C; Jensen, FT; Mosekilde, L, 1994)
"We studied 21 women with postmenopausal osteoporosis, treated with salmon calcitonin nasal spray (100 IU/daily) and calcium (1 g/daily) for six months."	( Montemagno, U; Riccio, S; Romano, L; Ronsini, S; Tolino, A, 1993)
"Women with primary postmenopausal osteoporosis who were untreated (n = 15) or treated with estrogen (n = 17)."	( Cosman, F; Lindsay, R; Ratcliffe, A; Seibel, M; Shen, V; Xie, F, 1993)
"Estrogen treatment prevents early postmenopausal bone loss."	( Insua, A; Negri, A; Zanchetta, JR, 1995)
"Especially in conditions like postmenopausal osteoporosis, where no readily accessable marker of treatment response is available, the development of sCT antibodies and their possible neutralizing effect has to be considered."	( Grauer, A; Raue, F; Ziegler, R, 1995)
"Bone loss associated with postmenopausal osteoporosis can be reduced by treatment with antiresorptive agents such as estrogen or bisphosphonates."	( Black, EC; Bryant, HU; Chandrasekhar, S; Frolik, CA; Magee, DE, 1996)
"Five years of etidronate therapy for postmenopausal osteoporosis results in significant increases in vertebral bone mineral content, and the previously observed reduction in vertebral fracture rate in the etidronate group is maintained during at least 5 years of therapy."	( Genant, HK; Kollerup, G; Storm, T; Sørensen, OH; Thamsborg, G, 1996)
"Treatment of postmenopausal osteoporosis by interval IV bolus injections of the bisphosphonate ibandronate was safe and effective in increasing BMD through a dose-dependent inhibition of bone resorption."	( Burckhardt, P; Huss, H; Juttmann, JR; Kriegbaum, H; Mulder, H; Schöter, KH; Thiébaud, D, 1997)
"Most medical treatment of postmenopausal osteoporosis are inhibitors of bone resorption and urinary deoxypyridinoline (D-Pyr) has been shown to be a reliable indicator of bone resorption."	( Ho, LM; Lim, BC; Sim, ML; Yu, SL, 1998)
"Thus, a therapy that could prevent postmenopausal bone loss and lower serum cholesterol concentrations without stimulating reproductive tissues would be desirable."	( Nishizawa, Y; Shioi, A, 1999)
"Tamoxifen prevents postmenopausal bone loss as efficiently as hormone replacement treatment, and lowers blood lipids and the coronary risk, but increases the risk of endometrial cancer; for this reason it cannot be used in the prevention of postmenopausal osteoporosis."	( Burckhardt, P, 1999)
"Risedronate prevents postmenopausal bone loss, decreases fracture in those with established postmenopausal osteoporosis, effectively treats Paget disease, and prevents corticosteroid-induced bone loss."	( Crandall, C, 2001)
"Antiresorptive treatments for postmenopausal osteoporosis have been studied extensively, but due to the volume of published data and lack of head-to-head trials, it is difficult to evaluate and compare their fracture reduction efficacy."	( Heath, H; Marcus, R; Stock, JL; Wong, M, 2002)
"In women with postmenopausal osteoporosis (PMO), response to therapy with bisphosphonates is conventionally monitored using central-site (hip and spine) bone mineral density (BMD), but more convenient alternatives are desirable."	( Banville, C; Brown, JP; Drake, WM; Kendler, DL, 2002)
"The aim of treatment of postmenopausal osteoporosis is to reduce the frequency of vertebral and non-vertebral fractures (especially at the hip), which are responsible for morbidity associated with the disease."	( Delmas, PD, 2002)
"The bisphosphonates are used to treat postmenopausal osteoporosis because they decrease the risk of fractures."	( Doggrell, SA, 2002)
"Treatment of postmenopausal osteoporosis with 50 mg i."	( Adami, S; Battaglia, E; Braga, V; Colapietro, F; Gatti, D; Prizzi, R; Righetti, D; Rossini, M, 2003)
"The therapy of postmenopausal osteoporosis is based on a few comprehensible assumptions."	( Keck, E, 2003)
"Treatment of postmenopausal osteoporosis with strontium ranelate leads to early and sustained reductions in the risk of vertebral fractures."	( Badurski, JE; Balogh, A; Cannata, J; Genant, HK; Lemmel, EM; Meunier, PJ; Ortolani, S; Pors-Nielsen, S; Reginster, JY; Rizzoli, R; Roux, C; Seeman, E; Spector, TD, 2004)
"To prevent and treat postmenopausal osteoporosis, women should be encouraged to perform weight-bearing exercise, to not smoke, and to optimize calcium and vitamin D intake through diet and supplements."	( Kessenich, C, 2003)
"In contrast to postmenopausal osteoporosis, there are only few studies on the treatment of osteoporosis in men; two different compounds (alendronate and teriparatide) appear to be equally effective in men and women."	( Kerschan-Schindl, K; Pietschmann, P, 2004)
"All patients with postmenopausal osteoporosis (PMOP) in this clinical trial had been allocated into 4 groups: placebo therapy group, vitamin D addition calcium therapy group, hormone replacement treatment (HRT) therapy group, and risedronate therapy group."	( Hu, YF; Sun, ZQ, 2005)
"All studied subjects (n=51) had postmenopausal osteoporosis, had been receiving long-term treatment with glucocorticoid plus estrogen or estrogen/progesterone and were randomly allocated either to a group receiving hPTH, 400 U/day (n=28), or to a control group (n=23)."	( Hurley, M; Lane, NE; Yao, W, 2005)
"Significantly more women with postmenopausal osteoporosis preferred once-monthly ibandronate therapy to once-weekly alendronate therapy, and found the once-monthly regimen to be more convenient."	( Beusterien, K; Devas, V; Emkey, R; Kivitz, A; Koltun, W; Masanauskaite, D; Seidman, L, 2005)
"In a pivotal study in postmenopausal osteoporosis, oral ibandronate, administered daily or with a between-dose interval of >2 months, demonstrated robust antifracture efficacy and an overall incidence of upper GI adverse events similar to placebo, even in patients at increased risk of such events."	( Delmas, PD; Emkey, R; Epstein, S; Hiltbrunner, V; Schimmer, RC; Wilson, KM, 2006)
"A total of 1,041 postmenopausal osteoporosis cases were classified into 4 categories, Young controls (n = 165) and Old controls (n = 95) (Control group), Young (n = 309) and Old osteoporosis (n = 110) treated with alendronate (ALN group), and Young (n = 238) and Old osteoporosis (n = 124) treated with vitamins D3 or K2 (VDK group)."	( Shiraki, M, 2006)
"The main goal of postmenopausal osteoporosis treatment is to reduce the risk of fragility fractures."	( Thomas, T, 2006)
"Effective prevention of postmenopausal osteoporosis at the individual level requires early screening of women at risk of fractures and their early treatment."	( Ribot, C; Trémollières, F, 2006)
"TPTD therapy in women with postmenopausal osteoporosis results in acute increase in serum RANKL levels but does not affect serum OPG."	( Anastasilakis, AD; Avramidis, A; Gerou, S; Goulis, DG; Koukoulis, G; Pavlidou, V; Polyzos, SA, 2008)
"In 117 women suffering from postmenopausal osteoporosis, quality of life was measured before and 26 weeks after therapy using the International Osteoporosis Foundation Qualeffo-41 score, and pain intensity was measured using a visual analogue scale."	( Buttgereit, F; Krocker, D; Perka, C; Ullrich, H, 2008)
"Several treatments for postmenopausal osteoporosis have become available over the last decade, but adherence to treatment is inadequate and the prevention of non-vertebral fracture by those medications is still modest."	( Chapurlat, RD, 2008)
"Our findings indicate that treatment of postmenopausal osteoporosis with strontium ranelate results in a sustained reduction in the incidence of osteoporotic nonvertebral fractures, including hip fractures, and vertebral fractures over 5 years."	( Balogh, A; Boonen, S; Brandi, ML; Brixen, K; Cormier, C; Delmas, PD; Diez-Perez, A; Felsenberg, D; Goemaere, S; Meunier, PJ; Reginster, JY; Rizzoli, R; Spector, TD, 2008)
"Effective treatment of postmenopausal osteoporosis with raloxifen is related to excellent cooperation of patients on a long-term basis."	( Payer, J; Rosa, J; Svobodník, A; Vanuga, P, 2008)
"We studied 1515 women with postmenopausal osteoporosis under treatment with anti-resorbing agents (alendronate, risedronate, raloxifene) for 13."	( Adami, S; Bianchi, G; Di Munno, O; Fiore, CE; Giannini, S; Minisola, S; Rossini, M; Sinigaglia, L, 2009)
"Treatment of postmenopausal osteoporosis (PMO) is based primarily on antiresorptive agents, including hormone replacement therapy (HT)."	( Christiansen, C; Fogelman, I; Fordham, JN; Fox, J; Fraser, WD; Morris, SA; Spector, TD, 2008)
"Forty women (age, 55-80 years) with postmenopausal osteoporosis (treated with ALN, RIS and RLX or untreated-control group) were given infusions of sodium ethylenediaminetetraacetic acid (EDTA; 10 mg/kg of body weight)."	( Stepan, JJ; Zikan, V, 2009)
"Current treatments for postmenopausal osteoporosis suffer from side effects."	( Betageri, GV; Bharadwaj, S; Naidu, AG; Naidu, AS; Prasadarao, NV, 2009)
"This study was performed on women with postmenopausal osteoporosis from the Spinal Osteoporosis Therapeutic Intervention (SOTI) and Treatment of Peripheral Osteoporosis (TROPOS) studies."	( Benhamou, CL; Briot, K; Fechtenbaum, J; Kolta, S; Roux, C; Said-Nahal, R, 2010)
"To describe strategies used in managing postmenopausal osteoporosis, including a bone-healthy lifestyle, adequate calcium and vitamin D intake, and drug therapy options; considerations in selecting osteoporosis drug therapy; and the role of health-system pharmacists in managing osteoporosis in postmenopausal women."	( Vondracek, SF, 2010)
"The Asian postmenopausal osteoporosis patients in this study had a high adherence rate to once-monthly ibandronate therapy."	( Adam, JM; Albert, A; Cañete, A; de la Rosa, M; Gamilla, Z; Hsu, HC; Kung, AW; Lan, JL; Leerapan, T; Lin, HY; Lin, RM; Luevitoonvechkij, S; Navarra, S; Ngarmukos, S; Rachman, IA; Roeshadi, D; Rojanasthien, S; Songpatanasilp, T; Soong, YK; Soontrapa, S; Torralba, T; Tsai, K; Tu, ST; Vanbelle, S; Yuktanandana, P, 2009)
"A new target in treating postmenopausal osteoporosis is the tissue estrogen complex or the pairing of a SERM with a conjugated estrogen known as a tissue selective estrogen complex (TSEC)."	( Bolognese, MA, 2010)
"This drug is used to treat postmenopausal osteoporosis in women with a high risk of fracture."	( Palacios, S, 2011)
"135 patients with postmenopausal osteoporosis were randomly assigned to the control group A (treated with Calcichew D3 Tablet), the control group B (treated with Calcichew D3 Tablet and Xianling Gubao Capsule), and the treatment group (treated with Calcichew D5 Tablet and embedding thread according to staging and wholism syndrome differentiation)."	( Huang, CJ; Liang, DB; Liu, BX, 2011)
"The primary goal of treatment for postmenopausal osteoporosis is the reduction in fracture risk."	( Rizzoli, R, 2012)
"The primary objective of postmenopausal osteoporosis treatment is to reduce the risk of fragility fracture."	( Thomas, T, 2012)
"FDP-Sr may be an effectve treatment for postmenopausal osteoporosis that acts, in part, via a decrease in osteoclastogenesis through the OPG\\RANKL\\RANK pathway."	( Cheng, YP; Hu, YY; Ma, B; Wang, YL; Wu, D; Yang, ZD; Ying, HJ; Zhang, Q; Zheng, YY, 2012)
"Fifty women with established postmenopausal osteoporosis were randomized to 12-month treatment with 20 μg of TPTD, administered daily in the morning or in the evening."	( Kubena, AA; Luchavova, M; Michalska, D; Raska, I; Stepan, JJ; Zikan, V, 2012)
"The Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) study was a randomized, double-blind, double-dummy, active- and placebo-controlled, multiple-dose, phase 3 study to assess the efficacy and safety of oral recombinant calcitonin for treatment of postmenopausal osteoporosis."	( Binkley, N; Bolognese, M; Buben, CE; Gilligan, JP; Krause, DS; Miller, C; Sidorowicz-Bialynicka, A; Trout, R; Vally, T, 2012)
"A total of 101 women with postmenopausal osteoporosis aged >60 years were randomly stratified into two groups-R group (n = 51), treated with risedronate alone; and R + K group (n = 50), treated with risedronate and vitamin K2."	( Aizawa, T; Chida, S; Ebina, T; Hongo, M; Ishikawa, Y; Kasukawa, Y; Miyakoshi, N; Nozaka, K; Saito, H; Shimada, Y, 2014)
"To analyze expenditure on treatment for postmenopausal osteoporosis and associated factors on mean per capita expenditure."	( Acurcio, Fde A; Andrade, EI; Brandão, CM; Cherchiglia, ML; Ferré, F; Guerra, AA; Machado, GP, 2013)
"In women with postmenopausal osteoporosis, continuous treatment with ibandronate over 5 years results in low sustained clinical fracture rate."	( Barr, C; Day, BM; Felsenberg, D; Harris, S; Masanauskaite, D; Miller, PD; Recker, RR; Reginster, J; Silverman, S, 2014)
"Of the 112,445 women with treated postmenopausal osteoporosis, 6,487 received strontium ranelate."	( Borer, JS; Cooper, C; Fox, KM, 2014)
"The effect of exercise treating postmenopausal osteoporosis is tightly correlated with the up-regulation of expression of OPG."	( Wang, J; Wang, Q; Yang, M, 2013)
"For many patients, adhering to postmenopausal osteoporosis treatment is a challenge."	( Agodoa, I; Bonnick, S; Brown, JP; Ferreira, I; Ho, PR; Palacios, S; Van den Bergh, JP, 2015)
"129 patients with postmenopausal osteoporosis (32 non-pretreatment, 50 bisphosphonates, 18 SERM, and 29 teriparatide) were recruited and switched to DMAb plus eldecalcitol."	( Asano, T; Hamano, H; Hiratsuka, S; Iwasaki, N; Ota, M; Sato, D; Shimizu, T; Takahashi, D; Takahata, M, 2019)
"In women with postmenopausal osteoporosis, we investigated the effects of 24 months of treatment with alendronate (ALN) following 18 months of treatment with abaloparatide (ABL) or placebo (PBO)."	( Bilezikian, JP; Bone, HG; Cosman, F; Dore, RK; Fitzpatrick, LA; Hattersley, G; Hu, MY; Miller, PD; Mitlak, B; Papapoulos, S; Rizzoli, R; Saag, KG; Williams, GC, 2018)
"We report on 120 women with postmenopausal osteoporosis who were treated with 60 mg denosumab every 6 months for 2 to 5 years (mean duration 3 years) and then 5 mg zoledronate 6 months after the last denosumab injection."	( Everts-Graber, J; Lehmann, T; Reichenbach, S; Studer, U; Ziswiler, HR, 2020)
"Patients with postmenopausal osteoporosis either switched from MIN to denosumab (Group 1; n = 32) or continued MIN treatment (Group 2; n = 24)."	( Ishida, K; Kimura, T; Kobayashi, M; Komura, N; Miyamoto, M; Sawada, K; Shimizu, A; Shimura, K; Yamamoto, M; Yoshimura, A, 2020)
"In this study, a total of 41 postmenopausal osteoporosis patients under regular raloxifene treatment were included."	( Adikusuma, W; Chang, WC; Chou, PH; Chou, WH; Hung, KS; Lin, GH; Lu, HF; Mugiyanto, E; Wang, ST, 2020)
"One-hundred forty-eight patients with postmenopausal osteoporosis were recruited; their therapy was switched from BPs or NBPs to Zol or DMAb plus ELD (BP-Zol: 43, NBP-Zol: 32, BP-DMAb: 35, and NBP-DMAb: 38)."	( Asano, T; Ishizu, H; Iwasaki, N; Nakamura, Y; Shimizu, T; Shimodan, S; Takahashi, D; Takahata, M, 2021)
"For the treatment of postmenopausal osteoporosis, current guidelines recommend initial treatment with bisphosphonates, but it is unclear whether bisphosphonates provide a similar degree of therapeutic efficacy in patients with diabetes."	( Baek, KH; Kang, MI; Kim, J; Kim, KM; Lim, S; Min, YK, 2022)
"In conclusion, we propose that postmenopausal osteoporosis could be prevented or treated with herbal products."	( Ashokan, B; Behl, T; Bungau, SG; Chigurupati, S; Meerasa, SS; Rashid, S; Shah, OP; Sharma, A; Sharma, C, 2023)
"She had been treated for postmenopausal osteoporosis with 70 mg of alendronate weekly for 2 years."	( Fernandes, TL; Franco, GCN; Jitumori, C; Viezzer Fernandes, B, 2023)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	53 (0.88)	23.3326
1990's	1545 (25.73)	12.5806
2000's	2352 (39.17)	18.1394
2010's	1658 (27.61)	28.8240
2020's	397 (6.61)	9.53

Drug	Relationship Strength	Studies	Trials
acetic acid	low	1	0
adenine	medium	2	1
ammonium hydroxide	medium	1	1
beta-alanine	low	1	0
1-butanol	low	1	0
methane	medium	1	1
citric acid, anhydrous	medium	12	7
chlorine	medium	2	2
coumarin	low	1	0
salicylic acid	low	1	0
gallic acid	low	1	0
hydrogen sulfide	low	2	0
n(g),n(g')-dimethyl-l-arginine	low	1	0
creatine	medium	8	5
cytosine	medium	2	1
lactic acid	medium	3	1
glutaric acid	low	1	0
glycine	low	1	0
glycerol	medium	1	1
hydrogen carbonate	medium	7	1
histamine	medium	1	1
hydrogen	medium	2	1
iodine	medium	4	1
phytic acid	medium	4	1
inositol	low	2	0
melatonin	medium	6	1
nickel	low	1	0
nitrates	medium	5	2
nitrites	medium	1	1
phthalic acid	low	1	0
picolinic acid	low	1	0
propylene glycol	medium	1	1
succinic acid	low	1	0
sulfur dioxide	medium	1	1
taurine	low	1	0
thymine	medium	1	1
uric acid	medium	12	5
1-anilino-8-naphthalenesulfonate	low	1	0
mercaptoethanol	low	1	0
acetaminophen	medium	2	2
alendronate	medium	1,009	329
althiazide	low	1	0
amitriptyline	low	1	0
amlodipine	medium	2	1
anastrozole	medium	14	7
aspirin	medium	3	1
benzothiazide	medium	1	1
berberine	medium	3	2
bicalutamide	low	1	0
bumetanide	medium	1	1
caffeine	medium	17	1
carbamazepine	low	1	0
chloroquine	low	1	0
chlorthalidone	medium	1	1
cilostazol	low	1	0
cimetidine	medium	1	1
citalopram	medium	1	1
clonidine	low	1	0
3,3'-diindolylmethane	low	1	0
valproic acid	low	2	0
erythrosine	low	1	0
etidronate	medium	478	170
felodipine	low	1	0
fenofibrate	low	1	0
fentanyl	low	1	0
flufenamic acid	low	1	0
fluorouracil	low	1	0
fluoxetine	low	1	0
furosemide	low	1	0
hydrochlorothiazide	medium	7	4
hydroxychloroquine	low	2	0
ibuprofen	medium	2	2
lidocaine	medium	1	1
imipramine	low	1	0
indapamide	medium	1	1
indomethacin	low	1	0
iohexol	low	1	0
iomeprol	low	1	0
ipriflavone	medium	42	26
isoflurane	medium	1	1
2-propanol	low	2	0
ketamine	medium	1	1
lansoprazole	low	1	0
lauric acid	low	1	0
letrozole	medium	18	12
loxoprofen	low	1	0
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	low	1	0
memantine	medium	2	1
metformin	medium	5	1
methadone	medium	3	1
methoxsalen	low	1	0
methyl salicylate	medium	1	1
metoprolol	low	1	0
minoxidil	low	1	0
activins	low	3	0
nifedipine	low	1	0
nitroglycerin	medium	4	2
omeprazole	low	3	0
oxybutynin	low	1	0
oxymetazoline	low	1	0
pamidronate	medium	45	13
phloretin	low	1	0
pioglitazone	low	2	0
promethazine	medium	1	1
rabeprazole	low	1	0
raloxifene	low	1	0
sanguinarine	low	1	0
sodium fluoride	medium	79	23
iodoacetic acid	low	1	0
risedronic acid	medium	379	128
sulfasalazine	medium	1	1
sulpiride	medium	2	1
triclosan	low	1	0
trientine	low	2	0
corticosterone	low	1	0
prednisolone	medium	14	5
estriol	medium	23	12
thymidine	low	2	0
hydroxyproline	medium	135	59
thyroxine	medium	32	3
norethindrone acetate	medium	21	16
spironolactone	low	3	0
prednisolone acetate	low	1	0
aldosterone	medium	2	1
prednisone	medium	24	7
estrone	medium	27	13
androsterone	low	4	0
etiocholanolone	low	2	0
dehydroepiandrosterone	medium	27	1
triiodothyronine	medium	11	5
carbon tetrachloride	low	1	0
alanine	low	2	0
serine	low	3	0
lysine	medium	10	1
ethinyl estradiol	medium	12	5
galactose	low	1	0
carbostyril	low	2	0
edetic acid	medium	8	5
phenylethyl alcohol	low	1	0
tyrosine	low	1	0
androstenedione	medium	7	1
lactose	medium	5	1
phenylalanine	low	1	0
colchicine	low	1	0
cycloheximide	low	1	0
norethindrone	medium	36	27
asparagine	low	1	0
histidine	medium	2	2
medroxyprogesterone acetate	medium	56	33
valine	low	3	0
mestranol	low	1	0
alizarin	medium	1	1
tryptophan	low	2	0
arginine	medium	11	2
ethylene	medium	1	1
quinic acid	low	1	0
bisphenol a	low	1	0
methylmethacrylate	low	2	0
taurocholic acid	medium	1	1
methylprednisolone	medium	7	1
isosorbide dinitrate	medium	4	4
quinoxalines	medium	1	1
propylparaben	low	1	0
4-butyrolactone	low	1	0
pyrrolidonecarboxylic acid	medium	3	1
trehalose	low	1	0
triethanolamine	low	1	0
caprolactam	medium	1	1
pyrroles	medium	4	3
thiophenes	medium	221	46
isopropyl myristate	medium	1	1
estradiol dipropionate	low	1	0
quinestrol	medium	11	3
dydrogesterone	medium	16	11
catechin	low	3	0
quinazolines	low	2	0
indazoles	low	1	0
benzoxazoles	medium	1	1
isoxazoles	low	2	0
oxazoles	low	1	0
thiazoles	medium	2	1
pyrazines	medium	1	1
calcium gluconate	low	4	0
testosterone enanthate	low	1	0
nandrolone decanoate	medium	20	13
cyproterone acetate	medium	6	5
nandrolone	medium	29	17
fluorobenzenes	medium	1	1
limestone	medium	50	30
berbamine	low	1	0
plumbagin	low	1	0
osthol	low	3	0
4-hydroxyphenylethanol	low	1	0
thiazolidines	medium	10	8
oleanolic acid	low	2	0
hesperidin	medium	2	1
medroxyprogesterone	medium	36	19
dihydrotestosterone	low	2	0
angelicin	low	1	0
copper gluconate	low	1	0
muscone	medium	1	1
malondialdehyde	medium	7	1
chlorotrianisene	low	1	0
3-hydroxyflavone	low	1	0
allyl sulfide	low	1	0
acetylcysteine	medium	2	1
c.i. 42510	medium	1	1
dehydroepiandrosterone sulfate	medium	23	1
levonorgestrel	medium	6	5
calcium citrate	medium	15	12
calcium lactate	medium	3	2
potassium citrate	medium	7	4
deoxycytidine	medium	3	1
durapatite	medium	26	7
vancomycin	low	1	0
glycyrrhizic acid	low	2	0
d-alpha tocopherol	medium	13	1
1,2-epoxyhexane	medium	1	1
bisphenol a-glycidyl methacrylate	low	1	0
sabinene	low	2	0
mannose	low	1	0
megestrol	medium	1	1
carbonates	low	2	0
fructosamine	low	1	0
manganese	medium	4	1
silver	medium	1	1
thulium	medium	1	1
titanium	medium	7	1
cadmium	medium	7	1
europium	low	1	0
uranium	medium	1	1
acetylglucosamine	low	1	0
phosphoric acid, trisodium salt	medium	1	1
barium sulfate	low	1	0
calcium phosphate, dibasic, anhydrous	low	3	0
calcium phosphate, monobasic, anhydrous	low	3	0
tricalcium phosphate	medium	15	5
fluorine	medium	2	1
calcium pyrophosphate	low	2	0
ethinyl estradiol-norgestrel combination	low	1	0
galactose	medium	1	1
ozone	medium	1	1
trolamine salicylate	low	11	0
stanozolol	medium	2	1
clodronic acid	medium	33	19
estetrol	medium	1	1
isosorbide-5-mononitrate	medium	4	4
tetradecanoylphorbol acetate	low	1	0
fluorides	medium	106	23
danazol	medium	1	1
carbimazole	low	1	0
phenyl acetate	low	4	0
cetylpyridinium chloride anhydrous	medium	9	1
4-ethylphenol	low	1	0
triamcinolone	low	1	0
transferrin	low	2	0
calcium oxalate	medium	3	3
glutamic acid	low	1	0
tramadol	medium	2	1
levormeloxifene	medium	6	3
paclitaxel	medium	1	1
etoposide	low	1	0
substance p	low	2	0
promegestone	medium	4	1
ng-nitroarginine methyl ester	low	1	0
1-carboxyglutamic acid	medium	1	1
desogestrel	medium	5	4
captopril	low	2	0
agreal	medium	2	1
buserelin	low	1	0
fomesafen	medium	2	1
lovastatin	low	4	0
simvastatin	medium	10	3
pravastatin	low	4	0
raloxifene hydrochloride	medium	561	163
mifepristone	low	1	0
nitrogenase stabilizing-protective protein, bacteria	low	1	0
fadrozole	low	1	0
aromasil	medium	4	1
gemcitabine	medium	3	1
atorvastatin	medium	6	4
duloxetine hydrochloride	low	1	0
valsartan	low	1	0
ibandronic acid	medium	184	71
tiludronic acid	medium	10	2
adenosine	low	1	0
potassium phosphate	medium	1	1
glucose, (beta-d)-isomer	low	6	0
ursolic acid	low	1	0
baicalin	medium	2	1
allicin	medium	1	1
fluorexon	low	1	0
testosterone undecanoate	low	1	0
fluorophosphate	medium	21	14
pyrrolidine dithiocarbamate	low	1	0
iopamidol	low	1	0
tomatidine	low	1	0
telmisartan	low	1	0
2-methoxyestradiol	low	2	0
triazoles	medium	32	19
pentafluoropropionic anhydride	low	1	0
fluorodeoxyglucose f18	medium	4	1
zoledronic acid	medium	239	79
nomegestrol	medium	1	1
dienogest	low	2	0
drospirenone	medium	4	3
trimegestone	low	2	0
beta-hydroxyisovaleric acid	low	1	0
6-amino-1-hydroxyhexane-1,1-diphosphonate	medium	7	4
dapoxetine	medium	1	1
bindarit	low	1	0
voriconazole	medium	2	1
sesamin	low	1	0
nobiletin	low	1	0
rosiglitazone	medium	4	1
ethyl 2-cyanoacrylate	medium	1	1
3,4-dihydroxyphenylethanol	low	1	0
loganin	low	1	0
o-desmethylangolensin	low	1	0
nicotine	medium	1	1
fibrinogen	medium	5	3
equol	medium	12	3
homocysteine	medium	23	3
lopinavir	medium	1	1
annatto	low	2	0
diosgenin	low	3	0
cobalt	low	1	0
fulvestrant	low	5	0
ici 164384	low	1	0
calcium phosphate, dibasic, dihydrate	medium	1	1
vitamin b 6	low	1	0
sr141716	low	1	0
ly 117018	low	3	0
1,n(6)-ethenoadenine	medium	1	1
pyridinoline	medium	77	22
deoxypyridinoline	medium	134	51
thiamethoxam	medium	1	1
procyanidin	low	1	0
2,3-bis(3'-hydroxybenzyl)butyrolactone	low	1	0
valerates	low	1	0
tanshinone	low	1	0
listerine	medium	1	1
toosendanin	low	1	0
sophocarpine	low	1	0
dioscin	low	2	0
pentosidine	low	7	0
valdecoxib	low	1	0
delta-hydroxylysylnorleucine	medium	1	1
peroxynitrous acid	medium	1	1
imatinib mesylate	medium	1	1
gefitinib	medium	1	1
trisequens	medium	2	2
n(6)-carboxymethyllysine	low	3	0
technetium tc 99m hydroxymethylene diphosphonate	medium	1	1
angiotensin ii, des-phe(8)-	low	1	0
23-seleno-25-homotaurocholic acid	medium	1	1
n,n-dimethylarginine	low	1	0
galactosylhydroxylysine	low	4	0
iguratimod	low	1	0
methotrexate	medium	8	3
beta-lactorphin	low	1	0
cyanidin	low	1	0
ym 529	medium	16	8
docosyl-triethylenetetraminepentaacetic acid	low	2	0
calcium borate	medium	1	1
proline	low	1	0
docetaxel anhydrous	medium	1	1
ezetimibe	low	2	0
bazedoxifene	medium	88	22
naproxen	low	3	0
cinacalcet	low	1	0
curculigoside	low	1	0
celastrol methyl ester	low	1	0
cryptotanshinone	low	1	0
isoflavanone	low	2	0
sweroside	low	2	0
leonurine	low	1	0
platycodin d	low	1	0
sclareol	low	1	0
methylinositol	low	1	0
calcium pyrophosphate	low	3	0
thyroxine, triiodothyronine drug combination	low	1	0
anacardic acid	low	1	0
17 alpha-hydroxyprogesterone caproate	low	1	0
5-hydroxyhexanoic acid	low	1	0
angiotensin ii	low	1	0
organophosphonates	low	1	0
ly 353381	medium	12	5
olpadronic acid	low	1	0
lasofoxifene	medium	29	6
deoxycholic acid	low	1	0
estradiol 3-benzoate	low	1	0
cortisone	low	4	0
methenolone enanthate	low	1	0
benzofurans	low	2	0
medicarpin	low	1	0
ritonavir	medium	1	1
cimadronate	low	2	0
dihydropyridines	low	1	0
permanganate	medium	1	1
carboplatin	medium	2	1
glycogen	low	1	0
fibrin	low	1	0
carnosine	medium	2	1
mevalonic acid	low	1	0
naringenin	low	1	0
epiglucan	medium	1	1
oxytocin	medium	5	1
tartaric acid	low	2	0
vicenin ii	low	1	0
lignans	low	6	0
eplerenone	low	2	0
tibolone	medium	94	35
betadex	low	1	0
tretinoin	medium	2	1
arachidonic acid	low	1	0
resveratrol	medium	8	1
retinol	low	14	0
tacrolimus	low	2	0
farnesyl pyrophosphate	low	1	0
cocaine	medium	1	1
eicosapentaenoic acid	medium	4	1
clindamycin	low	2	0
lycopene	medium	7	1
diethylstilbestrol	low	4	0
decitabine	low	1	0
iridoids	medium	2	1
shikonin	low	1	0
8-prenylnaringenin	medium	4	1
riboflavin	medium	4	1
maltitol	low	1	0
2,3-bis(bromomethyl)quinoxaline-1,4-dioxide	medium	1	1
potassium bicarbonate	low	6	0
dipyrone	low	1	0
bromochloroacetic acid	low	1	0
trans-4-coumaric acid	low	1	0
glycosides	low	6	0
isomethyleugenol	low	3	0
stilbenes	low	6	0
buprenorphine	low	2	0
pyrophosphate	low	3	0
leuprolide	medium	3	2
sesquiterpenes	low	1	0
ethyl ferulate	low	1	0
cotinine	low	1	0
curcumin	medium	4	2
methimazole	low	2	0
capsaicin	low	2	0
enclomiphene	low	1	0
chlorogenic acid	low	2	0
D-fructopyranose	low	1	0
tamoxifen	medium	103	16
methyl-thiohydantoin-tryptophan	low	1	0
zeranol	low	1	0
estrone sulfate	medium	2	2
ranitidine	medium	1	1
toremifene	low	4	0
u 0126	low	1	0
lithium	low	1	0
nitrogen dioxide	medium	1	1
hydroxylysine	low	4	0
droloxifene	low	7	0
gestodene	medium	3	2
orlistat	low	1	0
idoxifene	medium	2	1
tat 59	low	1	0
ospemifene	medium	5	1
methenolone	low	1	0
freedom	medium	2	1
oxalylglycine	low	1	0
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine	low	2	0
prolyl-4-hydroxyproline	low	1	0
17-ketosteroids	low	3	0
naphthoquinones	low	3	0
osteoprotegerin	medium	154	19
sphingosine	low	4	0
quercetin	low	5	0
bilirubin	medium	5	3
dinoprostone	low	9	0
formononetin	low	1	0
apigenin	low	1	0
luteolin	low	1	0
calcitriol	medium	176	63
quercitrin	low	1	0
vitamin k semiquinone radical	medium	50	8
beta carotene	low	4	0
vitamin d 2	medium	18	5
stigmasterol	low	1	0
cholecalciferol	medium	125	64
rutin	low	1	0
zeaxanthin	low	1	0
lipoxin a4	low	2	0
gamma-linolenic acid	medium	1	1
genistein	medium	32	8
montelukast	low	1	0
cryptoxanthins	low	3	0
harpagoside	low	1	0
oleuropein	medium	1	1
baicalein	medium	2	1
chrysin	low	1	0

Protein Targets (2,973)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Cytochrome P450 2C9	0	47	3	52
IDH1	50	0	0	50
chromobox protein homolog 1	85	0	0	85
geminin	138	0	0	138
Chain B, pheromone binding protein	0	0	1	1
Chain A, pheromone binding protein	0	0	1	1
Chain A, JmjC domain-containing histone demethylation protein 3A	33	0	0	33
Chain A, RNA-directed RNA polymerase NS5	0	3	0	3
acid sphingomyelinase	9	0	0	9
thioredoxin reductase	69	0	0	69
USP1 protein, partial	86	0	0	86
TDP1 protein	163	0	0	163
vitamin D3 receptor isoform VDRA	55	0	0	55
importin subunit beta-1 isoform 1	18	0	0	18
flap endonuclease 1	37	0	0	37
serine/threonine-protein kinase PLK1	14	0	0	14
snurportin-1	18	0	0	18
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	23	0	0	23
GTP-binding nuclear protein Ran isoform 1	11	0	0	11
DNA polymerase eta isoform 1	18	0	0	18
DNA polymerase iota isoform a (long)	50	0	0	50
urokinase-type plasminogen activator precursor	26	0	0	26
plasminogen precursor	26	0	0	26
urokinase plasminogen activator surface receptor precursor	26	0	0	26
DNA polymerase kappa isoform 1	53	0	0	53
fibroblast growth factor 22 isoform 1 precursor	0	0	0	3
Mitogen-activated protein kinase 13	0	1	3	4
Beta-lactamase	0	2	0	2
Transthyretin	0	8	7	17
Fatty acid-binding protein, intestinal	0	6	3	9
Fatty acid-binding protein, adipocyte	0	4	2	6
Cyclin-A2	0	2	0	2
Cannabinoid receptor 1	0	4	3	7
Cyclin-dependent kinase 2	0	6	7	13
Choline O-acetyltransferase	0	1	0	1
Mitogen-activated protein kinase 12	0	1	3	4
Guanine nucleotide-binding protein G	21	0	0	21
Fatty acid-binding protein 5	0	2	1	3
Fatty acid-binding protein 5	0	0	2	2
Mitogen-activated protein kinase 11	0	1	5	6
Mitogen-activated protein kinase 14	0	14	5	19
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	71	0	0	71
aldehyde dehydrogenase 1 family, member A1	95	0	0	95
glucocorticoid receptor [Homo sapiens]	137	0	0	137
farnesoid X nuclear receptor	86	0	0	86
estrogen nuclear receptor alpha	205	0	0	205
Voltage-dependent calcium channel gamma-2 subunit	78	0	0	78
Cellular tumor antigen p53	119	0	0	119
Glutamate receptor 2	81	2	1	84
Choline O-acetyltransferase	0	1	0	2
Chain A, Ferritin light chain	41	0	0	41
glp-1 receptor, partial	42	0	0	42
phosphopantetheinyl transferase	57	0	0	57
hypoxia-inducible factor 1 alpha subunit	50	0	0	50
RAR-related orphan receptor gamma	139	0	0	139
SMAD family member 2	57	0	0	57
Fumarate hydratase	29	0	0	29
SMAD family member 3	57	0	0	57
GLI family zinc finger 3	125	0	0	125
Microtubule-associated protein tau	83	0	0	83
AR protein	185	0	0	185
Smad3	39	0	0	39
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	37	0	0	37
estrogen receptor 2 (ER beta)	95	0	0	95
nuclear receptor subfamily 1, group I, member 3	104	0	0	104
progesterone receptor	103	0	0	103
cytochrome P450 family 3 subfamily A polypeptide 4	105	0	0	105
retinoic acid nuclear receptor alpha variant 1	133	0	0	133
retinoid X nuclear receptor alpha	109	0	0	109
estrogen-related nuclear receptor alpha	148	0	0	148
pregnane X nuclear receptor	117	0	0	117
G	87	0	0	87
cytochrome P450 2D6	77	0	0	77
polyprotein	29	0	0	29
67.9K protein	45	0	0	45
bromodomain adjacent to zinc finger domain 2B	32	0	0	32
peroxisome proliferator-activated receptor delta	83	0	0	83
peroxisome proliferator activated receptor gamma	99	0	0	99
vitamin D (1,25- dihydroxyvitamin D3) receptor	85	0	0	85
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	104	0	0	104
thyroid stimulating hormone receptor	55	0	0	55
activating transcription factor 6	51	0	0	51
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	56	0	0	56
v-jun sarcoma virus 17 oncogene homolog (avian)	66	0	0	66
Histone H2A.x	51	0	0	51
Caspase-7	11	0	0	11
nuclear factor erythroid 2-related factor 2 isoform 2	41	0	0	42
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	29	0	0	29
caspase-3	11	0	0	11
thyroid hormone receptor beta isoform 2	127	0	0	127
heat shock protein beta-1	55	0	0	55
huntingtin isoform 2	17	0	0	17
nuclear factor erythroid 2-related factor 2 isoform 1	123	0	0	123
nuclear receptor ROR-gamma isoform 1	67	0	0	67
survival motor neuron protein isoform d	56	0	0	56
replicative DNA helicase	0	0	0	1
recombinase A	0	0	1	1
lamin isoform A-delta10	116	0	0	116
neuropeptide S receptor isoform A	24	0	0	24
Interferon beta	113	0	0	113
HLA class I histocompatibility antigen, B alpha chain	87	0	0	87
Alpha-synuclein	19	14	1	34
Spike glycoprotein	67	2	11	80
Inositol hexakisphosphate kinase 1	87	0	0	87
cytochrome P450 2C9, partial	87	0	0	87
dopamine D1 receptor	7	0	0	7
GLS protein	60	0	0	60
regulator of G-protein signaling 4	42	0	0	42
euchromatic histone-lysine N-methyltransferase 2	113	0	0	113
histone acetyltransferase KAT2A isoform 1	47	0	0	47
Adenosine receptor A3	0	32	4	37
Adenosine receptor A1	0	17	3	25
Adenosine receptor A3	0	3	0	3
Adenosine receptor A2a	0	17	6	25
Adenosine receptor A2b	0	2	2	6
Adenosine receptor A2b	0	6	2	10
Adenosine receptor A1	0	17	4	24
Adenosine receptor A2a	0	18	4	29
Adenosine receptor A1	0	2	2	4
Mu-type opioid receptor	0	17	3	20
ATP-dependent phosphofructokinase	53	0	0	53
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, HADH2 protein	54	0	0	54
Chain B, HADH2 protein	54	0	0	54
Chain A, 2-oxoglutarate Oxygenase	56	0	0	56
Chain A, Cruzipain	31	0	0	31
Chain A, Methyltransferase Wbdd	0	1	0	1
15-lipoxygenase, partial	32	0	0	32
ATAD5 protein, partial	58	0	0	58
NFKB1 protein, partial	17	0	0	17
Thrombopoietin	15	0	0	15
thyroid stimulating hormone receptor	58	0	0	58
EWS/FLI fusion protein	86	0	0	87
Parkin	20	0	0	20
cytochrome P450 2D6 isoform 1	31	0	0	31
cellular tumor antigen p53 isoform a	34	0	0	34
cytochrome P450 2C19 precursor	37	0	0	37
cytochrome P450 2C9 precursor	31	0	0	31
serine/threonine-protein kinase mTOR isoform 1	20	0	0	20
cytochrome P450 3A4 isoform 1	71	0	0	71
M-phase phosphoprotein 8	26	0	0	26
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	4	4	9
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	4	0	4
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	0	1	0	1
Serine/threonine-protein kinase PLK4	0	3	5	8
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	1	3	4
Gamma-aminobutyric acid receptor subunit pi	71	4	3	78
Polyunsaturated fatty acid lipoxygenase ALOX15B	27	6	0	33
Bromodomain-containing protein 4	0	1	0	1
5-hydroxytryptamine receptor 4	0	30	1	31
cGMP-specific 3',5'-cyclic phosphodiesterase	0	8	0	9
Integrin beta-3	27	2	1	30
Cytochrome P450 1A2	0	21	1	26
Integrin alpha-IIb	27	1	1	29
Neuronal acetylcholine receptor subunit alpha-4	5	6	3	15
Serine/threonine-protein kinase pim-1	0	7	6	15
Neuronal acetylcholine receptor subunit beta-2	5	6	3	15
Gamma-aminobutyric acid receptor subunit beta-1	71	4	3	78
Gamma-aminobutyric acid receptor subunit delta	71	4	3	78
Gamma-aminobutyric acid receptor subunit gamma-2	71	4	3	78
Casein kinase II subunit alpha'	0	9	5	14
Gamma-aminobutyric acid receptor subunit alpha-5	71	4	3	78
Gamma-aminobutyric acid receptor subunit alpha-3	71	4	3	78
Gamma-aminobutyric acid receptor subunit gamma-1	71	4	3	78
Gamma-aminobutyric acid receptor subunit alpha-2	71	4	3	78
Proteinase-activated receptor 1	0	1	1	3
Bromodomain-containing protein 2	0	1	0	1
Phosphatidylinositol 3-kinase regulatory subunit alpha	0	2	0	3
5-hydroxytryptamine receptor 2A	0	30	1	31
5-hydroxytryptamine receptor 2C	0	31	1	32
Gamma-aminobutyric acid receptor subunit alpha-4	71	4	3	78
Gamma-aminobutyric acid receptor subunit gamma-3	71	4	3	78
Gamma-aminobutyric acid receptor subunit alpha-6	71	4	3	78
Sodium-dependent serotonin transporter	0	17	1	19
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Type-1 angiotensin II receptor	0	3	0	3
5-hydroxytryptamine receptor 2B	0	34	1	35
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	6	4	11
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	4	4	10
Serine/threonine-protein kinase mTOR	0	8	5	13
Serine/threonine-protein kinase mTOR	0	1	0	1
Histamine H2 receptor	46	4	2	53
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	5	4	10
Glycogen synthase kinase-3 beta	0	8	5	13
D(1A) dopamine receptor	9	0	0	9
Serine/threonine-protein kinase PLK1	0	7	5	12
Gamma-aminobutyric acid receptor subunit alpha-1	71	5	3	79
Gamma-aminobutyric acid receptor subunit beta-3	71	4	3	78
Gamma-aminobutyric acid receptor subunit beta-2	71	4	3	78
Casein kinase II subunit beta	0	9	0	9
Casein kinase II subunit alpha	0	10	3	13
DNA-dependent protein kinase catalytic subunit	0	4	0	4
Serine-protein kinase ATM	0	2	0	2
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	6	0	7
Serine/threonine-protein kinase ATR	0	2	1	3
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	6	0	7
Bromodomain-containing protein 3	0	1	0	1
Serine/threonine-protein kinase pim-3	0	1	3	4
Phosphoinositide 3-kinase regulatory subunit 5	0	1	0	1
GABA theta subunit	71	4	3	78
Gamma-aminobutyric acid receptor subunit epsilon	71	4	3	78
Serine/threonine-protein kinase PLK3	0	5	3	8
Serine/threonine-protein kinase PLK2	0	4	3	7
Chain A, Beta-lactamase	43	0	0	43
PPM1D protein	36	0	0	36
glucocerebrosidase	28	0	0	28
lysosomal alpha-glucosidase preproprotein	16	0	0	16
interferon gamma precursor	0	0	0	3
atrial natriuretic peptide receptor 2 precursor	11	0	0	11
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	7	1	0	8
Tubulin alpha-1A chain	0	3	2	6
Tubulin beta chain	0	3	2	5
Sex hormone-binding globulin	0	1	20	21
Cytochrome P450 1A1	0	16	2	19
TAR DNA-binding protein 43	34	0	0	34
Cytochrome P450 1B1	0	22	1	23
Tubulin beta-2B chain	0	5	1	8
Similar to alpha-tubulin isoform 1	0	4	1	7
Similar to alpha-tubulin isoform 1	0	4	0	6
thyroid hormone receptor beta isoform a	49	0	0	49
Hepatocyte growth factor receptor	0	5	5	10
apical membrane antigen 1, AMA1	15	0	0	15
mitogen-activated protein kinase 1	45	0	0	45
Carbonic anhydrase 12	0	25	1	36
Carbonic anhydrase 1	0	48	1	66
Carbonic anhydrase 2	0	54	2	74
ATP-dependent translocase ABCB1	0	36	8	52
Calmodulin-1	0	6	0	6
Androgen receptor	1	32	12	57
Pyruvate kinase PKM	0	6	1	7
Polyunsaturated fatty acid lipoxygenase ALOX15	0	7	0	7
Polyunsaturated fatty acid lipoxygenase ALOX12	0	6	0	6
Xanthine dehydrogenase/oxidase	0	20	0	20
Fatty acid synthase	0	12	0	12
Carbonic anhydrase 9	0	25	1	37
Aurora kinase B	0	8	6	14
Dipeptidyl peptidase 3	0	7	0	7
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	3
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	44	0	0	44
DNA topoisomerase type IB small subunit	0	0	1	1
DNA topoisomerase I	0	0	1	1
Aryl hydrocarbon receptor	0	0	2	2
Nuclear receptor ROR-gamma	37	2	2	41
G-protein coupled receptor 84	0	0	1	1
G-protein coupled receptor 84	0	1	2	4
Polyunsaturated fatty acid 5-lipoxygenase	0	19	0	19
Chain A, Trichosurin	0	0	1	1
Sulfotransferase 1A1	0	0	0	2
Replicase polyprotein 1ab	0	32	17	49
Carbonic anhydrase 5A, mitochondrial	0	20	1	31
Carbonic anhydrase	0	2	0	2
Beta-carbonic anhydrase 1	0	5	0	5
Carbonic anhydrase	0	3	0	9
Carbonic anhydrase	0	3	0	9
Carbonic anhydrase 5B, mitochondrial	0	19	1	30
Rapamycin-insensitive companion of mTOR	0	1	0	1
Regulatory-associated protein of mTOR	0	2	0	2
Phosphatidylinositol 3-kinase catalytic subunit type 3	0	0	1	1
Target of rapamycin complex 2 subunit MAPKAP1	0	1	0	1
Target of rapamycin complex subunit LST8	0	2	0	2
Trypsin-1	0	4	0	4
Trypsin-2	0	4	0	4
Cyclic AMP-responsive element-binding protein 1	0	0	0	2
Trypsin-3	0	4	0	4
Receptor-type tyrosine-protein kinase FLT3	0	8	5	13
Geranylgeranyl pyrophosphate synthase	0	10	0	12
Farnesyl pyrophosphate synthase	0	15	0	15
Chain A, Avidin	0	0	2	2
Chain A, Avidin	0	0	2	2
Chain B, Avidin	0	0	2	2
Voltage-dependent T-type calcium channel subunit alpha-1G	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1H	0	1	0	1
Estrogen receptor	1	60	16	83
Amine oxidase [flavin-containing] A	0	24	0	24
Amine oxidase [flavin-containing] B	0	25	0	25
NAD(P)H dehydrogenase [quinone] 1	0	0	0	4
Estrogen receptor beta	1	34	14	52
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	26	2	30
aryl hydrocarbon receptor	62	0	0	62
peripheral myelin protein 22	69	0	0	69
ATP-binding cassette sub-family C member 3	0	90	0	90
Multidrug resistance-associated protein 4	0	94	0	99
Solute carrier family 22 member 6	0	15	0	15
UDP-glucuronosyltransferase 1A9	0	0	0	2
Bile salt export pump	0	14	0	15
Bile salt export pump	0	118	0	119
Cytochrome P450 2B1	0	2	0	3
Cytochrome P450 1A1	0	0	0	1
Myoglobin	0	1	0	1
Prostaglandin G/H synthase 1	0	21	2	24
Carbonic anhydrase 3	0	17	1	23
Cytochrome P450 3A4	0	46	4	55
Cytochrome P450 2D6	0	22	3	25
Polyunsaturated fatty acid lipoxygenase ALOX15	0	13	0	13
UDP-glucuronosyltransferase 1-6	0	3	0	5
Arachidonate 5-lipoxygenase-activating protein	0	1	1	2
UDP-glucuronosyltransferase 1A1	0	8	0	12
Carbonic anhydrase 4	0	31	1	42
Prostaglandin G/H synthase 1	0	28	0	28
Carbonic anhydrase 6	0	19	1	29
Prostaglandin G/H synthase 2	0	30	5	37
Carbonic anhydrase 7	0	23	1	33
Cytochrome P450 2J2	0	24	0	24
Canalicular multispecific organic anion transporter 1	0	86	0	87
Carbonic anhydrase 15	0	13	0	18
Carbonic anhydrase 13	0	15	0	23
Carbonic anhydrase 14	0	17	1	27
toxin B	0	0	0	1
Free fatty acid receptor 3	0	0	1	1
Free fatty acid receptor 2	0	1	1	2
Tyrosine-protein kinase Lck	0	5	7	12
Tyrosine-protein kinase Fyn	0	10	6	16
Fibrinogen C domain-containing protein 1	0	1	0	1
Chain A, ATP-DEPENDENT DNA HELICASE Q1	17	0	0	17
acetylcholinesterase	51	0	0	51
pregnane X receptor	27	0	0	27
arylsulfatase A	33	0	0	33
Bloom syndrome protein isoform 1	34	0	0	34
D(1A) dopamine receptor	17	0	0	17
muscarinic acetylcholine receptor M1	25	0	0	25
Histone deacetylase 3	0	8	0	8
Histone deacetylase 4	0	8	0	8
Histone deacetylase 1	0	11	0	11
Histone deacetylase 7	0	8	0	8
Histone deacetylase 2	0	11	0	11
Polyamine deacetylase HDAC10	0	8	0	8
Histone deacetylase 11	0	8	0	8
Ataxin-2	66	0	0	66
Histone deacetylase 8	0	9	1	10
Histone deacetylase 6	0	10	0	10
Histone deacetylase 9	0	8	0	8
Histone deacetylase 5	0	8	0	8
Putative glycosyltransferase WbgO	0	0	0	1
Killer cell lectin-like receptor subfamily B member 1A	0	1	0	1
Early activation antigen CD69	0	1	0	1
Chain A, MTA/SAH nucleosidase	0	1	0	1
Chain A, Ribosome-inactivating protein alpha-trichosanthin	0	0	1	1
Chain A, Ricin A chain	0	0	1	1
Chain A, Ribosome-inactivating protein 3	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
tumor susceptibility gene 101 protein	4	0	0	4
Cyclin-dependent kinase 1	0	11	5	16
Heat shock protein HSP 90-beta	0	1	0	1
Protein mono-ADP-ribosyltransferase PARP15	0	2	0	2
Leucine-rich repeat serine/threonine-protein kinase 2	0	2	3	5
ATPase family AAA domain-containing protein 5	53	0	0	53
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	3	0	0	3
NPYLR7B	0	0	2	2
glycogen synthase kinase-3 beta isoform 1	0	0	7	7
high affinity choline transporter 1 isoform a	0	2	0	2
Sodium/nucleoside cotransporter 1	0	2	0	2
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	4	4
Sodium/nucleoside cotransporter 2	0	2	0	2
Rap guanine nucleotide exchange factor 3	21	0	0	21
Purine nucleoside phosphorylase	0	3	0	3
Epidermal growth factor receptor	0	21	6	27
Phosphoglycerate kinase 1	0	1	0	1
Adenosine deaminase	0	0	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	0	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	4	0	4
Receptor tyrosine-protein kinase erbB-2	0	7	3	10
Insulin receptor	0	2	5	8
Phosphoglycerate kinase 2	0	1	0	1
Heat shock protein HSP 90-alpha	0	1	2	3
Platelet-derived growth factor receptor beta	0	2	5	8
Heat shock 70 kDa protein 1A	0	1	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
Fibroblast growth factor receptor 1	0	4	5	10
Inosine-5'-monophosphate dehydrogenase 2	0	1	5	6
Endoplasmin	0	1	1	2
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Fibroblast growth factor receptor 2	0	0	3	4
Fibroblast growth factor receptor 4	0	0	3	4
Fibroblast growth factor receptor 3	0	1	3	5
Streptavidin	0	0	1	1
Adenosylhomocysteinase	0	0	0	1
Adenylate kinase 2, mitochondrial	0	1	0	1
Adenylate kinase isoenzyme 1	0	1	0	1
Phosphatidylinositol 4-kinase alpha	0	2	0	3
Adenosine kinase	0	0	5	6
Adenosine deaminase	0	0	0	1
Equilibrative nucleoside transporter 2	0	2	0	2
Phosphatidylinositol 4-kinase type 2-beta	0	2	0	3
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Equilibrative nucleoside transporter 1	0	3	0	3
Phosphatidylinositol 4-kinase type 2-alpha	0	2	0	3
Solute carrier family 28 member 3	0	3	0	3
Adenosine kinase	0	1	0	2
Phosphatidylinositol 4-kinase beta	0	2	3	6
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	0	0	1
potassium voltage-gated channel subfamily H member 2 isoform d	45	0	0	45
Alanine racemase, biosynthetic	0	0	0	1
5-hydroxytryptamine receptor 1D	0	1	0	5
Glutamate receptor ionotropic, NMDA 1	0	14	3	23
Proton-coupled amino acid transporter 1	0	10	0	10
Adenosine deaminase	0	0	0	1
Carbonic anhydrase 4	0	3	0	7
Corticosteroid-binding globulin	0	12	0	12
Mineralocorticoid receptor	1	12	6	21
Androgen receptor	0	60	1	62
Mineralocorticoid receptor	0	5	0	5
Solute carrier organic anion transporter family member 1A1	0	7	0	12
Chain A, farnesyl pyrophosphate synthase	0	1	0	1
Acetylcholinesterase	0	28	0	28
Hypoxanthine-guanine phosphoribosyltransferase	0	3	0	3
Farnesyl pyrophosphate synthase	0	7	0	7
Farnesyl pyrophosphate synthase	0	3	0	3
Bile acid receptor	0	6	2	8
Luciferase	65	0	0	65
endonuclease IV	16	0	0	16
WRN	5	0	0	5
polyunsaturated fatty acid lipoxygenase ALOX12	11	0	0	11
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	43	0	0	43
histone deacetylase 9 isoform 3	18	0	0	18
dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	0	3
Vpr	8	0	0	8
kelch-like ECH-associated protein 1	0	0	0	2
Gag-Pol polyprotein	0	2	0	2
Apoptosis regulator Bcl-2	0	2	0	2
D(3) dopamine receptor	0	6	0	6
Glutamate receptor 1	3	2	1	6
Glutamate receptor 3	3	2	1	6
Glutamate receptor 4	3	2	1	6
Inositol monophosphatase 1	24	0	0	24
Induced myeloid leukemia cell differentiation protein Mcl-1	0	3	0	3
RmtA	0	1	0	1
Reverse transcriptase/RNaseH	0	3	1	4
Protein arginine N-methyltransferase 1	0	1	0	1
phosphoglycerate kinase	3	0	0	3
Transient receptor potential cation channel subfamily V member 1	0	2	2	4
Transient receptor potential cation channel subfamily A member 1	0	1	6	8
Procathepsin L	0	11	12	23
Cathepsin B	0	7	1	8
Transient receptor potential cation channel subfamily A member 1	0	0	3	3
Transient receptor potential cation channel subfamily V member 1	0	2	1	5
Cysteine protease	0	2	0	2
Mitochondrial 2-oxodicarboxylate carrier	0	1	0	1
serine-protein kinase ATM isoform a	5	0	0	5
Solute carrier family 22 member 1	0	20	0	24
Voltage-dependent L-type calcium channel subunit alpha-1F	0	8	0	8
Albumin	0	0	5	5
High affinity nerve growth factor receptor	0	2	7	9
Aldo-keto reductase family 1 member B1	0	48	0	48
Muscarinic acetylcholine receptor M2	0	18	2	22
Muscarinic acetylcholine receptor M4	0	16	0	17
Muscarinic acetylcholine receptor M1	0	6	3	9
Muscarinic acetylcholine receptor M3	0	5	3	8
Muscarinic acetylcholine receptor M4	0	5	3	8
5-hydroxytryptamine receptor 2C	0	8	0	9
Muscarinic acetylcholine receptor M5	0	5	3	8
Muscarinic acetylcholine receptor M5	0	18	0	19
Alpha-2A adrenergic receptor	0	34	6	41
Muscarinic acetylcholine receptor M2	0	5	3	8
Muscarinic acetylcholine receptor M1	0	21	1	24
Angiotensin-converting enzyme	0	14	0	15
D(2) dopamine receptor	0	17	2	20
5-hydroxytryptamine receptor 2A	0	10	0	10
Alpha-2B adrenergic receptor	0	29	3	33
Alpha-2C adrenergic receptor	0	28	4	33
5-hydroxytryptamine receptor 1A	0	23	3	28
Muscarinic acetylcholine receptor M3	0	24	2	27
D(1A) dopamine receptor	0	15	1	16
D(1B) dopamine receptor	0	1	0	1
UDP-glucuronosyltransferase 1A4	0	4	0	11
Sodium-dependent noradrenaline transporter	0	45	3	48
Histamine H2 receptor	0	13	2	15
Alpha-1D adrenergic receptor	0	23	3	27
5-hydroxytryptamine receptor 1B	0	19	1	20
5-hydroxytryptamine receptor 1D	0	3	1	4
5-hydroxytryptamine receptor 1F	0	3	1	4
5-hydroxytryptamine receptor 2B	0	7	0	7
5-hydroxytryptamine receptor 6	0	3	0	3
Histamine H1 receptor	0	4	1	5
Sodium-dependent serotonin transporter	0	41	4	45
5-hydroxytryptamine receptor 7	0	3	0	3
5-hydroxytryptamine receptor 5A	0	3	0	3
5-hydroxytryptamine receptor 5B	0	3	0	3
Histamine H1 receptor	0	16	3	19
D(3) dopamine receptor	0	28	1	31
Sodium channel protein type 1 subunit alpha	0	3	0	3
Sodium channel protein type 4 subunit alpha	0	6	0	7
UDP-glucuronosyltransferase 1A3	0	0	0	7
5-hydroxytryptamine receptor 3A	0	4	0	4
Alpha-1A adrenergic receptor	0	41	2	43
5-hydroxytryptamine receptor 6	0	25	1	26
5-hydroxytryptamine receptor 7	0	9	0	9
Voltage-dependent N-type calcium channel subunit alpha-1B	0	3	0	3
Sodium channel protein type 7 subunit alpha	0	3	0	3
Voltage-dependent L-type calcium channel subunit alpha-1D	0	8	0	8
Sodium-dependent dopamine transporter	0	34	1	35
Potassium voltage-gated channel subfamily H member 2	0	32	0	32
Voltage-dependent L-type calcium channel subunit alpha-1S	0	8	0	8
Voltage-dependent L-type calcium channel subunit alpha-1C	0	10	0	11
Sodium channel protein type 5 subunit alpha	0	5	0	5
Sodium channel protein type 9 subunit alpha	0	6	0	6
Sigma non-opioid intracellular receptor 1	0	6	2	8
5-hydroxytryptamine receptor 4	0	3	0	3
Nuclear receptor subfamily 3 group C member 3	0	10	0	10
Sodium channel protein type 2 subunit alpha	0	3	0	3
Sigma non-opioid intracellular receptor 1	0	29	1	30
5-hydroxytryptamine receptor 3B	0	4	0	4
Sodium channel protein type 3 subunit alpha	0	4	0	4
Sodium channel protein type 11 subunit alpha	0	3	0	3
Sodium channel protein type 8 subunit alpha	0	3	0	3
Histamine H3 receptor	0	6	2	9
Sodium channel protein type 10 subunit alpha	0	3	0	3
NEDD8-activating enzyme E1 regulatory subunit isoform a	0	1	0	1
NEDD8-conjugating enzyme Ubc12	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	4	0	4
Potassium channel subfamily K member 2	0	3	5	8
Alpha-2B adrenergic receptor	0	12	2	14
Voltage-dependent L-type calcium channel subunit alpha-1C	0	6	0	6
Alpha-2C adrenergic receptor	0	11	2	13
Alpha-2A adrenergic receptor	0	11	2	13
Alpha-1A adrenergic receptor	0	5	4	10
Alpha-1B adrenergic receptor	0	4	3	8
Potassium channel subfamily K member 2	0	2	0	2
Plasma kallikrein	0	1	0	8
Seed linoleate 13S-lipoxygenase-1	0	10	0	18
Peroxisome proliferator-activated receptor gamma	0	6	13	21
Peroxisome proliferator-activated receptor delta	0	3	2	7
Peroxisome proliferator-activated receptor alpha	3	5	7	15
Histone acetyltransferase p300	0	3	0	4
Probable linoleate 9S-lipoxygenase 5	0	1	0	1
Histone acetyltransferase KAT2B	0	2	0	2
Histone acetyltransferase KAT5	0	1	0	1
Histone acetyltransferase KAT8	0	2	0	4
SUMO-activating enzyme subunit 1	0	1	0	1
Aromatase	0	30	0	34
Amine oxidase [flavin-containing] A	0	7	1	8
Chain A, Androgen receptor	0	1	0	1
Chain A, Androgen receptor	0	1	0	1
Chain A, Androgen receptor	0	1	0	1
Chain A, Androgen receptor	0	1	0	1
Chain A, Androgen receptor	0	1	0	1
Nuclear factor NF-kappa-B p105 subunit	0	7	0	7
Signal transducer and activator of transcription 3	0	5	1	6
Hexokinase-2	0	1	0	1
interleukin 8	23	0	0	23
nonstructural protein 1	20	0	0	20
peripheral myelin protein 22 isoform 1	26	0	0	26
nuclear factor NF-kappa-B p105 subunit isoform 1	7	0	2	9
muscleblind-like protein 1 isoform 1	23	0	0	23
Beta-glucuronidase	0	3	0	3
Cholinesterase	0	9	0	9
Gastrin/cholecystokinin type B receptor	0	0	0	1
Testosterone 17-beta-dehydrogenase 3	0	9	0	9
Chain A, retinol dehydratase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	7	0	7
G-protein coupled bile acid receptor 1	0	1	9	10
Acetylcholinesterase	0	10	0	10
Replicase polyprotein 1a	0	10	11	21
Beta-secretase 1	0	13	0	14
Atrial natriuretic peptide receptor 3	0	1	0	1
Type-1A angiotensin II receptor	1	3	2	6
Type-1 angiotensin II receptor	0	0	1	1
Type-1B angiotensin II receptor	1	3	0	4
Type-1 angiotensin II receptor	0	6	4	12
Type-2 angiotensin II receptor	1	2	0	3
Type-2 angiotensin II receptor	0	4	0	4
Chain A, Putative fructose-1,6-bisphosphate aldolase	27	0	0	27
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	2	0	2
Chain A, Transthyretin	0	0	4	4
Chain A, Transthyretin	0	0	4	4
Chain A, Transthyretin	0	0	4	4
Chain A, Transthyretin	0	0	4	4
Chain B, Transthyretin	0	0	4	4
Chain A, Transthyretin	0	0	4	4
Chain B, Transthyretin	0	0	4	4
Chain A, Casein kinase II subunit alpha	0	2	0	2
Chain A, Casein kinase II subunit alpha	0	2	0	2
Chain A, Casein Kinase Ii Subunit Alpha	0	2	0	2
BRCA1	11	0	0	11
RGS12	2	0	0	2
Neuraminidase	0	14	0	14
pyruvate kinase	5	0	0	5
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	20	0	0	20
Replicase polyprotein 1ab	0	6	12	18
NPC intracellular cholesterol transporter 1 precursor	15	0	0	15
hemoglobin subunit beta	5	0	0	5
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	2	0	0	2
ubiquitin carboxyl-terminal hydrolase 2 isoform a	15	0	0	15
pyruvate kinase PKM isoform b	4	0	0	4
Gamma-aminobutyric acid receptor subunit pi	0	7	0	7
Gamma-aminobutyric acid receptor subunit delta	0	7	0	7
Polyphenol oxidase 2	0	12	1	17
Aldo-keto reductase family 1 member B10	0	12	0	12
G2/mitotic-specific cyclin-B2	0	5	0	5
Poly [ADP-ribose] polymerase tankyrase-1	0	2	0	2
Lysozyme C-1	0	1	0	1
Cationic trypsin	0	3	0	3
Glucocorticoid receptor	1	40	7	63
Amyloid-beta precursor protein	2	17	1	22
Myeloperoxidase	0	5	0	5
Beta-glucuronidase	0	2	0	2
Neutrophil elastase	0	9	0	9
Ornithine decarboxylase	4	0	0	5
Poly [ADP-ribose] polymerase 1	0	2	0	2
Replicase polyprotein 1ab	0	4	11	15
Replicase polyprotein 1ab	0	23	13	36
Sialidase	0	5	0	5
Cystic fibrosis transmembrane conductance regulator	0	1	5	6
17-beta-hydroxysteroid dehydrogenase type 1	0	5	0	6
G2/mitotic-specific cyclin-B1	0	10	0	10
Gamma-aminobutyric acid receptor subunit alpha-1	0	7	1	8
Urease subunit alpha	0	9	0	9
Aldo-keto reductase family 1 member B1	0	19	0	19
G2/mitotic-specific cyclin-B	0	5	0	5
Mucin-1	0	1	0	1
Glycogen synthase kinase-3 beta	0	6	0	6
Gamma-aminobutyric acid receptor subunit beta-1	0	7	0	7
Gamma-aminobutyric acid receptor subunit gamma-2	0	7	1	8
Dipeptidyl peptidase 4	0	11	0	11
Proteasome subunit beta type-5	0	12	0	12
Gamma-aminobutyric acid receptor subunit beta-3	0	7	0	7
Substance-P receptor	0	16	0	17
Gamma-aminobutyric acid receptor subunit alpha-5	0	7	0	7
Multidrug resistance-associated protein 1	0	6	0	10
Gamma-aminobutyric acid receptor subunit alpha-3	0	7	0	7
Mu-type opioid receptor	0	26	5	37
17-beta-hydroxysteroid dehydrogenase type 2	0	6	0	6
Acetylcholinesterase	0	2	0	2
Peroxisome proliferator-activated receptor gamma	0	1	6	7
Delta-type opioid receptor	0	19	3	28
Kappa-type opioid receptor	0	24	4	34
Homeobox protein Nkx-2.5	0	2	0	2
Tyrosine-protein kinase SYK	0	5	9	14
Gamma-aminobutyric acid receptor subunit alpha-2	0	7	0	7
Gamma-aminobutyric acid receptor subunit beta-2	0	7	1	8
Gamma-aminobutyric acid receptor subunit alpha-4	0	7	0	7
Glycogen synthase kinase-3 alpha	0	5	5	10
Estrogen receptor	0	0	2	2
Death-associated protein kinase 1	0	8	3	11
Mitogen-activated protein kinase 10	0	9	5	14
Urease subunit beta	0	9	0	9
Gamma-aminobutyric acid receptor subunit epsilon	0	7	0	7
Disintegrin and metalloproteinase domain-containing protein 17	14	1	0	15
Lactoperoxidase	0	2	0	4
Xanthine dehydrogenase/oxidase	0	11	0	13
MO15-related protein kinase Pfmrk	0	3	0	3
Cyclin-dependent kinase 6	0	5	5	10
Cyclin-dependent-like kinase 5	0	6	5	11
Cyclin homolog	0	5	0	5
Transcription factor GATA-4	0	2	0	2
Cyclin-dependent kinase 5 activator 1	0	6	0	6
Gamma-aminobutyric acid receptor subunit alpha-6	0	7	0	7
Carbonic anhydrase 3	0	4	0	4
Substance-K receptor	0	10	0	10
Integrase	0	12	0	12
Gamma-aminobutyric acid receptor subunit gamma-1	0	7	0	7
Casein kinase II subunit alpha 3	0	7	0	7
Inositol polyphosphate multikinase	0	4	0	4
G2/mitotic-specific cyclin-B3	0	5	0	5
Enoyl-acyl-carrier protein reductase	0	8	0	8
NACHT, LRR and PYD domains-containing protein 3	0	2	0	2
Gamma-aminobutyric acid receptor subunit gamma-3	0	7	0	7
Myocilin	0	0	1	1
Cyclin-dependent kinase 1	0	5	0	5
Prenyltransferase homolog	0	0	0	5
Poly [ADP-ribose] polymerase tankyrase-2	0	3	0	3
MAP kinase-interacting serine/threonine-protein kinase 2	0	2	3	5
Carboxylic ester hydrolase	0	2	0	3
NADPH oxidase 4	0	3	0	3
Estrogen receptor beta	0	0	2	2
Inositol hexakisphosphate kinase 2	0	4	0	4
Short transient receptor potential channel 5	0	3	0	3
Gamma-aminobutyric acid receptor subunit theta	0	7	0	7
Sialidase-2	0	6	0	6
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	1	0	0	1
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	2	2
Chain A, SERUM ALBUMIN	0	0	2	2
thioredoxin glutathione reductase	23	0	0	23
lethal(3)malignant brain tumor-like protein 1 isoform I	8	0	0	8
caspase-1 isoform alpha precursor	8	0	0	8
Fatty-acid amide hydrolase 1	0	3	0	3
Prostaglandin G/H synthase 1	0	8	0	10
Trypsin	0	4	0	4
Coagulation factor VII	0	6	0	6
60 kDa chaperonin	0	8	0	8
60 kDa heat shock protein, mitochondrial	0	9	0	9
Tissue factor	0	9	0	9
Nuclear receptor subfamily 4 group A member 2	0	0	4	4
10 kDa heat shock protein, mitochondrial	0	9	0	9
Calmodulin	0	0	1	2
Prostaglandin G/H synthase 2	0	11	0	12
Solute carrier organic anion transporter family member 2A1	0	1	0	3
Thiosulfate sulfurtransferase	0	9	0	9
Lanosterol 14-alpha demethylase	0	3	0	3
60 kDa chaperonin	0	9	0	9
10 kDa chaperonin	0	9	0	9
Solute carrier organic anion transporter family member 1B3	0	27	0	34
Cytosolic phospholipase A2 gamma	0	2	0	2
Transient receptor potential cation channel subfamily V member 2	0	2	1	3
Solute carrier organic anion transporter family member 1B1	0	28	0	36
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	2	2
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	2	2
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	2	2
alpha-galactosidase	11	0	0	11
lethal factor (plasmid)	33	0	0	33
Nitric oxide synthase, endothelial	0	1	0	3
Nitric oxide synthase, brain	0	3	0	4
Nitric oxide synthase, brain	0	1	0	2
Nitric oxide synthase, inducible	0	6	0	7
Nitric oxide synthase, inducible	0	2	1	5
Cationic amino acid transporter 3	0	2	0	2
nuclear receptor subfamily 1, group I, member 2	27	0	0	27
Chain A, Hyaluronidase, phage associated	0	1	0	1
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	3	0	3
Urease	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	8	0	8
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	1	2	4
Egl nine homolog 1	0	3	4	8
Prolyl hydroxylase EGLN3	0	0	2	3
Hypoxia-inducible factor 1-alpha inhibitor	0	3	0	4
Solute carrier family 23 member 1	0	1	0	1
Neutral amino acid transporter A	0	4	0	4
Neutral amino acid transporter B(0)	0	4	0	4
Carbonic anhydrase-like protein, putative	0	0	0	7
Amino acid transporter	0	4	0	4
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	2	2
ras protein, partial	0	0	2	2
hypothetical protein, conserved	6	0	0	6
Rac1 protein	0	0	2	2
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	2	2
Prostaglandin-H2 D-isomerase	0	2	0	2
Prostaglandin G/H synthase 2	0	3	0	4
Fatty acid-binding protein, liver	0	7	1	8
Glutathione hydrolase 1 proenzyme	0	1	0	1
Urotensin-2 receptor	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	2
Ras-related protein Rab-2A	0	0	2	2
Rho-associated protein kinase 2	0	2	0	2
Nicotinate phosphoribosyltransferase	0	5	0	5
Solute carrier family 22 member 20	0	7	0	7
Solute carrier family 22 member 6	0	7	0	7
Sigma non-opioid intracellular receptor 1	0	5	2	7
caspase 7, apoptosis-related cysteine protease	29	0	0	29
caspase-3	29	0	0	29
Solute carrier organic anion transporter family member 2B1	0	8	0	12
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	6	0	6
Insulin receptor	0	4	0	4
Dipeptidyl peptidase 4	0	1	0	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	4	0	4
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	1	0	1
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	1	0	1
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	1	0	1
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	1	0	1
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	1	0	1
Leukotriene C4 synthase	0	0	3	3
tyrosine-protein kinase Yes	9	0	0	9
Bone morphogenetic protein receptor type-1B	0	0	5	5
Cell division cycle 7-related protein kinase	0	0	4	4
Serine/threonine-protein kinase 25	0	0	3	3
ATP-dependent RNA helicase DDX3X	0	0	5	5
Pyridoxal kinase	0	0	5	5
Citron Rho-interacting kinase	0	0	5	5
Serine/threonine-protein kinase RIO3	0	0	3	3
Dual specificity mitogen-activated protein kinase kinase 7	0	0	4	4
Serine/threonine-protein kinase Chk1	0	0	5	5
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	0	3	4
Peripheral plasma membrane protein CASK	0	0	3	3
Aurora kinase A	0	0	5	5
Cyclin-G-associated kinase	0	1	5	6
Serine/threonine-protein kinase DCLK1	0	0	3	3
Inhibitor of nuclear factor kappa-B kinase subunit alpha	0	0	3	3
Muscle, skeletal receptor tyrosine-protein kinase	0	0	3	3
Ephrin type-B receptor 6	0	0	5	5
Peroxisomal acyl-coenzyme A oxidase 3	0	0	5	5
3-phosphoinositide-dependent protein kinase 1	0	1	3	4
Mitogen-activated protein kinase kinase kinase 13	0	0	3	3
Death-associated protein kinase 3	0	0	3	3
Receptor-interacting serine/threonine-protein kinase 2	0	0	5	5
Mitotic checkpoint serine/threonine-protein kinase BUB1	0	0	5	5
NUAK family SNF1-like kinase 1	0	1	3	4
Dynamin-like 120 kDa protein, mitochondrial	0	0	5	5
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	0	0	3	3
Tyrosine-protein kinase JAK2	0	1	5	6
Eukaryotic translation initiation factor 5B	0	0	3	3
Rho-associated protein kinase 2	0	0	5	5
Serine/threonine-protein kinase ULK1	0	0	5	5
Serine/threonine-protein kinase/endoribonuclease IRE1	0	0	5	5
Ribosomal protein S6 kinase alpha-5	0	0	5	5
U5 small nuclear ribonucleoprotein 200 kDa helicase	0	0	5	5
Ribosomal protein S6 kinase alpha-4	0	0	5	5
Serine/threonine-protein kinase 16	0	0	5	5
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	0	0	3	3
Serine/threonine-protein kinase PAK 3	0	0	3	3
Cyclin-dependent kinase-like 5	0	0	4	4
Serine/threonine-protein kinase 17B	0	0	3	3
Serine/threonine-protein kinase 10	0	0	5	5
Serine/threonine-protein kinase D3	0	1	6	7
Cyclin-dependent kinase 14	0	0	3	3
Structural maintenance of chromosomes protein 2	0	0	5	5
Mitogen-activated protein kinase kinase kinase 6	0	0	5	5
Serine/threonine-protein kinase OSR1	0	0	3	3
Mitogen-activated protein kinase kinase kinase kinase 4	0	0	5	5
Serine/threonine-protein kinase LATS1	0	0	5	5
Serine/threonine-protein kinase PAK 4	0	0	5	5
Serine/threonine-protein kinase Chk2	0	0	3	3
Tyrosine-protein kinase ABL1	0	9	7	17
RAF proto-oncogene serine/threonine-protein kinase	0	1	3	4
Guanine nucleotide-binding protein G(i) subunit alpha-2	0	0	4	4
ADP/ATP translocase 2	0	0	5	5
Protein kinase C beta type	0	2	6	8
Glycogen phosphorylase, liver form	0	1	5	6
Tyrosine-protein kinase Fes/Fps	0	0	5	5
Macrophage colony-stimulating factor 1 receptor	0	1	3	4
Adenine phosphoribosyltransferase	0	0	4	4
Tyrosine-protein kinase Yes	0	4	5	9
Tyrosine-protein kinase Lyn	0	0	5	5
Proto-oncogene tyrosine-protein kinase receptor Ret	0	3	5	8
Insulin-like growth factor 1 receptor	0	2	5	7
Signal recognition particle receptor subunit alpha	0	0	5	5
Cytochrome c1, heme protein, mitochondrial	0	0	5	5
Tyrosine-protein kinase HCK	0	1	5	6
Proto-oncogene tyrosine-protein kinase ROS	0	2	3	5
Tyrosine-protein kinase Fgr	0	1	5	6
Wee1-like protein kinase 2	0	0	3	3
Uncharacterized serine/threonine-protein kinase SBK3	0	0	3	3
Serine/threonine-protein kinase A-Raf	0	0	5	5
Mast/stem cell growth factor receptor Kit	0	3	4	7
Glycogen phosphorylase, brain form	0	0	5	5
Breakpoint cluster region protein	0	2	6	9
DNA topoisomerase 2-alpha	0	2	6	14
Cyclin-dependent kinase 4	0	2	5	7
ADP/ATP translocase 3	0	0	5	5
Proto-oncogene tyrosine-protein kinase Src	0	7	5	12
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	0	5	5
Insulin receptor-related protein	0	0	3	3
Serine/threonine-protein kinase B-raf	0	3	5	8
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0	0	5	5
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	5	6	11
Platelet-derived growth factor receptor alpha	0	3	4	7
Tyrosine-protein kinase Fer	0	0	5	5
Protein kinase C alpha type	0	3	7	11
cAMP-dependent protein kinase catalytic subunit alpha	0	2	5	7
Vascular endothelial growth factor receptor 1	0	3	3	6
General transcription and DNA repair factor IIH helicase subunit XPD	0	0	5	5
Interferon-induced, double-stranded RNA-activated protein kinase	0	0	3	3
Ras-related protein Rab-6A	0	0	5	5
Serine/threonine-protein kinase MAK	0	0	3	3
Cyclin-dependent kinase 11B	0	0	3	3
Ephrin type-A receptor 1	0	0	5	5
Receptor tyrosine-protein kinase erbB-3	0	1	3	4
Multifunctional protein ADE2	0	0	5	5
cAMP-dependent protein kinase catalytic subunit gamma	0	1	4	5
cAMP-dependent protein kinase catalytic subunit beta	0	1	5	6
Ferrochelatase, mitochondrial	0	0	5	5
Ribosomal protein S6 kinase beta-1	0	1	5	6
Tyrosine-protein kinase JAK1	0	1	5	6
Protein kinase C eta type	0	1	4	5
Beta-adrenergic receptor kinase 1	0	0	5	5
Probable ATP-dependent RNA helicase DDX6	0	0	5	5
Activin receptor type-2A	0	0	3	3
Mitogen-activated protein kinase 3	0	0	5	5
MAP/microtubule affinity-regulating kinase 3	0	0	5	5
Deoxycytidine kinase	0	0	5	8
Mitogen-activated protein kinase 1	0	2	5	7
Ephrin type-A receptor 2	0	1	5	6
Ephrin type-A receptor 3	0	0	3	3
Ephrin type-A receptor 8	0	0	3	3
Ephrin type-B receptor 2	0	1	5	6
Leukocyte tyrosine kinase receptor	0	0	3	3
Non-receptor tyrosine-protein kinase TYK2	0	1	5	6
UMP-CMP kinase	0	0	4	4
Phosphatidylethanolamine-binding protein 1	0	0	4	4
Wee1-like protein kinase	0	0	5	5
Heme oxygenase 2	0	0	5	5
Tyrosine-protein kinase receptor UFO	0	2	3	5
Mitogen-activated protein kinase 4	0	0	3	3
S-adenosylmethionine synthase isoform type-2	0	0	5	5
DnaJ homolog subfamily A member 1	0	0	5	5
RAC-alpha serine/threonine-protein kinase	0	4	5	9
RAC-beta serine/threonine-protein kinase	0	1	5	6
G protein-coupled receptor kinase 4	0	0	3	3
Dual specificity protein kinase TTK	0	0	5	5
DNA replication licensing factor MCM4	0	0	5	5
Myosin-10	0	0	4	4
Tyrosine-protein kinase receptor Tie-1	0	0	3	3
Vascular endothelial growth factor receptor 3	0	2	3	5
Vascular endothelial growth factor receptor 2	0	6	3	9
Dual specificity mitogen-activated protein kinase kinase 2	0	2	5	7
Bone morphogenetic protein receptor type-1A	0	0	5	5
Activin receptor type-1B	0	0	5	5
TGF-beta receptor type-1	0	0	5	5
Serine/threonine-protein kinase receptor R3	0	0	4	4
TGF-beta receptor type-2	0	0	5	5
Electron transfer flavoprotein subunit beta	0	0	4	4
Tyrosine-protein kinase CSK	0	2	5	7
Glycine--tRNA ligase	0	0	5	5
Protein kinase C iota type	0	1	6	7
Exosome RNA helicase MTR4	0	0	5	5
Megakaryocyte-associated tyrosine-protein kinase	0	0	3	3
Tyrosine-protein kinase Tec	0	0	5	5
Tyrosine-protein kinase TXK	0	0	3	3
Tyrosine-protein kinase ABL2	0	1	5	6
Tyrosine-protein kinase FRK	0	0	5	5
G protein-coupled receptor kinase 6	0	1	5	6
Tyrosine-protein kinase ZAP-70	0	0	3	3
26S proteasome regulatory subunit 6B	0	0	5	5
Mitogen-activated protein kinase 8	0	1	5	6
Mitogen-activated protein kinase 9	0	1	5	6
Dual specificity mitogen-activated protein kinase kinase 4	0	1	4	5
Dual specificity mitogen-activated protein kinase kinase 3	0	0	5	5
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	1	0	5	6
Casein kinase I isoform alpha	0	1	5	6
Casein kinase I isoform delta	0	0	5	5
MAP kinase-activated protein kinase 2	0	0	5	5
Cyclin-dependent kinase 8	0	0	3	3
Elongation factor Tu, mitochondrial	0	0	5	5
Choline-phosphate cytidylyltransferase A	0	0	3	3
Cysteine--tRNA ligase, cytoplasmic	0	0	4	4
Casein kinase I isoform epsilon	0	0	5	5
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	0	0	5	5
Dual specificity protein kinase CLK1	0	0	5	5
Dual specificity protein kinase CLK2	0	0	5	5
Dual specificity protein kinase CLK3	0	0	5	5
Cyclin-dependent kinase 7	0	1	5	6
Cyclin-dependent kinase 9	0	0	5	5
Ras-related protein Rab-27A	0	0	5	5
Tyrosine-protein kinase Blk	0	0	3	3
Interleukin-1 receptor-associated kinase 1	0	0	5	5
Ribosomal protein S6 kinase alpha-3	0	0	5	5
Cytoplasmic tyrosine-protein kinase BMX	0	2	3	5
cAMP-dependent protein kinase catalytic subunit PRKX	0	0	3	3
Serine/threonine-protein kinase Nek2	0	1	5	6
Serine/threonine-protein kinase Nek3	0	0	5	5
Serine/threonine-protein kinase Nek4	0	0	3	3
Tyrosine-protein kinase JAK3	0	2	3	5
Dual specificity mitogen-activated protein kinase kinase 6	0	0	5	5
LIM domain kinase 1	0	0	5	5
LIM domain kinase 2	0	0	5	5
Tyrosine--tRNA ligase, cytoplasmic	0	0	5	5
5'-AMP-activated protein kinase subunit gamma-1	0	0	5	6
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	0	3	4
Ephrin type-B receptor 3	0	0	5	5
Ephrin type-A receptor 5	0	0	5	5
Ephrin type-B receptor 4	0	2	5	7
Ephrin type-B receptor 1	0	0	3	3
Ephrin type-A receptor 4	0	0	5	5
Adenylate kinase 2, mitochondrial	0	0	5	5
Hormonally up-regulated neu tumor-associated kinase	0	0	3	3
Serine/threonine-protein kinase SIK1	0	0	3	3
Receptor-interacting serine/threonine-protein kinase 4	0	0	3	3
Ras-related protein Rab-10	0	0	5	5
Cell division control protein 2 homolog	0	0	3	3
Actin-related protein 3	0	0	5	5
Actin-related protein 2	0	0	5	5
Calcium-dependent protein kinase 1	0	0	3	3
GTP-binding nuclear protein Ran	0	0	5	5
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	0	0	3	3
SRSF protein kinase 2	0	0	3	3
Casein kinase I isoform gamma-2	0	0	5	5
Mitogen-activated protein kinase kinase kinase 9	0	0	3	3
Serine/threonine-protein kinase PknB	0	0	3	3
Cyclin-dependent kinase 3	0	0	4	4
Cyclin-dependent kinase-like 1	0	0	3	3
Cyclin-dependent kinase 16	0	0	5	5
Cyclin-dependent kinase 17	0	0	5	5
ATP-dependent 6-phosphofructokinase, platelet type	0	0	5	5
Protein kinase C epsilon type	0	2	4	6
Dual specificity mitogen-activated protein kinase kinase 1	0	3	5	8
Angiopoietin-1 receptor	0	1	3	4
Mitogen-activated protein kinase kinase kinase 10	0	0	3	3
DNA topoisomerase 2-beta	0	2	6	14
Protein kinase C theta type	0	1	6	7
Activin receptor type-1	0	0	5	5
Macrophage-stimulating protein receptor	0	1	5	6
Focal adhesion kinase 1	0	1	5	6
Protein kinase C zeta type	0	1	5	6
Protein kinase C delta type	0	2	6	8
Tyrosine-protein kinase BTK	0	1	5	6
Tyrosine-protein kinase receptor TYRO3	0	1	3	4
Cyclin-dependent kinase 18	0	0	4	4
Activated CDC42 kinase 1	0	0	5	5
Epithelial discoidin domain-containing receptor 1	0	0	5	5
Tyrosine-protein kinase ITK/TSK	0	0	3	3
Myotonin-protein kinase	0	0	3	3
Mitogen-activated protein kinase kinase kinase kinase 2	0	0	5	5
Mitogen-activated protein kinase kinase kinase 12	0	0	3	3
Tyrosine-protein kinase Mer	0	2	4	6
Serine/threonine-protein kinase 4	0	0	5	5
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	0	5	6
Serine/threonine-protein kinase PAK 1	0	3	3	6
Dual specificity mitogen-activated protein kinase kinase 5	0	0	5	5
Mitogen-activated protein kinase 7	0	0	5	5
Serine/threonine-protein kinase PAK 2	0	0	4	4
Serine/threonine-protein kinase 3	0	0	5	5
Mitogen-activated protein kinase kinase kinase 1	0	0	5	5
cGMP-dependent protein kinase 2	0	0	3	3
Integrin-linked protein kinase	0	0	5	5
Rho-associated protein kinase 1	0	0	5	5
Non-receptor tyrosine-protein kinase TNK1	0	0	5	5
Serine/threonine-protein kinase PRP4 homolog	0	0	3	3
Receptor-interacting serine/threonine-protein kinase 1	0	1	4	5
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	3	4
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	0	5	5
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	0	5	5
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	5	5
Activin receptor type-2B	0	0	5	5
Bone morphogenetic protein receptor type-2	0	0	5	5
Protein-tyrosine kinase 6	0	0	5	5
cGMP-dependent protein kinase 1	0	0	5	5
Cyclin-dependent kinase 13	0	0	5	5
Calcium/calmodulin-dependent protein kinase type 1	0	0	3	3
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	0	0	5	5
Protein-tyrosine kinase 2-beta	0	0	5	5
Maternal embryonic leucine zipper kinase	0	0	5	5
Structural maintenance of chromosomes protein 1A	0	0	5	5
Chromodomain-helicase-DNA-binding protein 4	0	0	5	5
Peroxisomal acyl-coenzyme A oxidase 1	0	0	5	5
Serine/threonine-protein kinase D1	0	2	4	6
Serine/threonine-protein kinase 38	0	0	3	3
Receptor tyrosine-protein kinase erbB-4	0	1	3	4
Ribosomal protein S6 kinase alpha-2	0	0	3	3
Ephrin type-A receptor 7	0	0	4	4
Delta(24)-sterol reductase	0	0	5	5
Ribosomal protein S6 kinase alpha-1	0	0	5	5
Dual specificity testis-specific protein kinase 1	0	0	5	5
Myosin light chain kinase, smooth muscle	0	1	5	6
Serine/threonine-protein kinase STK11	0	0	5	5
Rhodopsin kinase GRK1	0	0	3	3
NT-3 growth factor receptor	0	0	3	3
Serine/threonine-protein kinase N1	0	1	5	6
Serine/threonine-protein kinase N2	0	1	5	6
Calcium/calmodulin-dependent protein kinase type IV	0	0	5	5
Mitogen-activated protein kinase kinase kinase 11	0	0	5	5
BDNF/NT-3 growth factors receptor	0	1	3	4
Mitogen-activated protein kinase 6	0	0	3	3
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	0	0	3	3
Discoidin domain-containing receptor 2	0	0	5	5
AP2-associated protein kinase 1	0	0	5	5
Myosin light chain kinase 3	0	0	5	5
Serine/threonine-protein kinase SBK1	0	0	3	3
Mitogen-activated protein kinase kinase kinase 19	0	0	3	3
Putative heat shock protein HSP 90-beta 2	0	0	5	5
Serine/threonine-protein kinase TNNI3K	0	0	3	3
Serine/threonine-protein kinase MRCK alpha	0	0	5	5
Serine/threonine-protein kinase MRCK gamma	0	0	5	5
Acyl-CoA dehydrogenase family member 10	0	0	5	5
Serine/threonine-protein kinase Nek5	0	0	3	3
Serine/threonine-protein kinase N3	0	0	5	5
Serine/threonine-protein kinase ULK3	0	0	5	5
Dual serine/threonine and tyrosine protein kinase	0	0	3	3
Mitogen-activated protein kinase kinase kinase 15	0	0	3	3
Uncharacterized protein FLJ45252	0	0	5	5
Acyl-CoA dehydrogenase family member 11	0	0	5	5
Serine/threonine-protein kinase/endoribonuclease IRE2	0	0	5	5
Serine/threonine-protein kinase MARK2	0	0	5	5
ATP-dependent RNA helicase DHX30	0	0	4	4
Serine/threonine-protein kinase TAO1	0	0	5	5
STE20-related kinase adapter protein alpha	0	0	5	5
Myosin-14	0	0	5	5
AarF domain-containing protein kinase 1	0	0	5	5
Serine/threonine-protein kinase tousled-like 2	0	0	3	3
Serine/threonine-protein kinase 32C	0	0	3	3
ATP-dependent RNA helicase DDX42	0	0	4	4
Serine/threonine-protein kinase VRK2	0	0	3	3
Myosin light chain kinase family member 4	0	0	3	3
Homeodomain-interacting protein kinase 1	0	0	3	3
Calcium/calmodulin-dependent protein kinase type 1D	0	0	3	3
Mitogen-activated protein kinase kinase kinase kinase 3	0	1	5	6
Cyclin-dependent kinase-like 3	0	0	3	3
MAP kinase-activated protein kinase 5	0	1	5	6
Serine/threonine-protein kinase BRSK2	0	0	3	3
Serine/threonine-protein kinase NIM1	0	0	3	3
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	0	0	2	2
Serine/threonine-protein kinase ULK2	0	0	3	3
Misshapen-like kinase 1	0	0	5	5
Serine/threonine-protein kinase DCLK2	0	0	3	3
Calcium/calmodulin-dependent protein kinase kinase 1	0	0	3	3
Casein kinase I isoform alpha-like	0	0	3	3
Homeodomain-interacting protein kinase 4	0	0	3	3
Myosin-IIIa	0	0	3	3
Ankyrin repeat and protein kinase domain-containing protein 1	0	0	3	3
Serine/threonine-protein kinase Nek11	0	0	3	3
Atypical kinase COQ8A, mitochondrial	0	0	5	5
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	0	0	5	5
Mitogen-activated protein kinase 15	0	0	5	5
Serine/threonine-protein kinase Nek9	0	0	5	5
Serine/threonine-protein kinase BRSK1	0	0	3	3
Serine/threonine-protein kinase 35	0	0	3	3
Serine/threonine-protein kinase Nek7	0	0	4	4
Rhodopsin kinase GRK7	0	0	3	3
Serine/threonine-protein kinase 32A	0	0	3	3
Myosin-IIIb	0	0	3	3
ATP-dependent RNA helicase DDX1	0	0	5	5
Dual specificity tyrosine-phosphorylation-regulated kinase 2	0	0	3	3
Cyclin-dependent kinase-like 2	0	0	3	3
Mitogen-activated protein kinase kinase kinase kinase 1	0	0	5	5
Serine/threonine-protein kinase Sgk3	0	0	3	3
Atypical kinase COQ8B, mitochondrial	0	0	3	3
MAP/microtubule affinity-regulating kinase 4	0	0	5	5
Calcium/calmodulin-dependent protein kinase type 1G	0	0	4	4
Serine/threonine-protein kinase Nek1	0	0	5	5
Cyclin-dependent kinase 15	0	0	3	3
PAS domain-containing serine/threonine-protein kinase	0	0	5	5
Calcium/calmodulin-dependent protein kinase kinase 2	0	0	5	5
EKC/KEOPS complex subunit TP53RK	0	0	5	5
SRSF protein kinase 1	0	0	3	3
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	0	2	5	7
Mitogen-activated protein kinase kinase kinase 5	0	0	5	5
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	0	0	3	3
Mitogen-activated protein kinase kinase kinase 3	0	0	5	5
Eukaryotic translation initiation factor 2-alpha kinase 1	0	0	5	5
Serine/threonine-protein kinase RIO1	0	0	3	3
MAP kinase-interacting serine/threonine-protein kinase 1	0	1	3	4
Serine/threonine-protein kinase RIO2	0	0	3	3
Cyclin-dependent kinase 19	0	0	3	3
Transient receptor potential cation channel subfamily M member 6	0	0	3	3
Testis-specific serine/threonine-protein kinase 1	0	0	3	3
Serine/threonine-protein kinase 33	0	0	3	3
Nucleolar GTP-binding protein 1	0	0	4	4
Serine/threonine-protein kinase D2	0	0	5	5
Serine/threonine-protein kinase DCLK3	0	0	3	3
NUAK family SNF1-like kinase 2	0	0	4	4
RNA cytidine acetyltransferase	0	0	5	5
Serine/threonine-protein kinase SIK2	0	0	5	5
Myosin light chain kinase 2, skeletal/cardiac muscle	0	0	3	3
STE20-like serine/threonine-protein kinase	0	0	5	5
Serine/threonine-protein kinase TAO3	0	0	5	5
Homeodomain-interacting protein kinase 2	0	0	3	3
Tyrosine-protein kinase Srms	0	0	3	3
Homeodomain-interacting protein kinase 3	0	0	3	3
dCTP pyrophosphatase 1	0	0	5	5
Dual specificity protein kinase CLK4	0	0	4	4
Serine/threonine-protein kinase Nek6	0	1	3	4
Casein kinase I isoform gamma-1	0	0	5	5
Serine/threonine-protein kinase PAK 6	0	0	4	4
SNF-related serine/threonine-protein kinase	0	0	3	3
Serine/threonine-protein kinase LATS2	0	0	3	3
Serine/threonine-protein kinase 36	0	0	3	3
Phenylalanine--tRNA ligase beta subunit	0	0	5	5
BMP-2-inducible protein kinase	0	0	5	5
Obg-like ATPase 1	0	0	4	4
Midasin	0	0	5	5
Interleukin-1 receptor-associated kinase 4	0	0	5	5
Serine/threonine-protein kinase 32B	0	0	3	3
Mitogen-activated protein kinase kinase kinase 20	0	0	5	5
Cyclin-dependent kinase 12	0	0	5	5
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	0	0	4	4
Serine/threonine-protein kinase MARK1	0	0	3	3
Serine/threonine-protein kinase pim-2	0	1	4	5
Serine/threonine-protein kinase PAK 5	0	0	3	3
Serine/threonine-protein kinase 26	0	0	5	5
eIF-2-alpha kinase GCN2	0	0	3	3
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	0	0	4	4
Serine/threonine-protein kinase NLK	0	0	5	5
Serine/threonine-protein kinase 17A	0	0	3	3
STE20/SPS1-related proline-alanine-rich protein kinase	0	0	3	3
Ephrin type-A receptor 6	0	0	3	3
5'-AMP-activated protein kinase subunit gamma-2	0	0	5	6
Serine/threonine-protein kinase TBK1	0	1	5	6
Septin-9	0	0	5	5
Death-associated protein kinase 2	0	0	3	3
Ribosomal protein S6 kinase alpha-6	0	0	5	5
TRAF2 and NCK-interacting protein kinase	0	0	5	5
Serine/threonine-protein kinase tousled-like 1	0	0	3	3
Serine/threonine-protein kinase TAO2	0	0	5	5
Long-chain-fatty-acid--CoA ligase 5	0	0	4	4
ALK tyrosine kinase receptor	0	7	4	11
SRSF protein kinase 3	0	0	3	3
Serine/threonine-protein kinase ICK	0	0	5	5
Cyclin-dependent kinase 11A	0	0	3	3
Aurora kinase C	0	0	3	3
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	1	3	4
RAC-gamma serine/threonine-protein kinase	0	0	5	5
Serine/threonine-protein kinase 38-like	0	0	3	3
Microtubule-associated serine/threonine-protein kinase 1	0	0	3	3
Serine/threonine-protein kinase SIK3	0	0	5	5
Mitogen-activated protein kinase kinase kinase 2	0	0	5	5
Thyroid hormone receptor-associated protein 3	0	0	5	5
Dual specificity tyrosine-phosphorylation-regulated kinase 1B	0	0	4	4
Mitogen-activated protein kinase kinase kinase kinase 5	0	0	5	5
Receptor-interacting serine/threonine-protein kinase 3	0	0	5	5
Serine/threonine-protein kinase MRCK beta	0	0	5	5
Interleukin-1 receptor-associated kinase 3	0	0	5	5
Serine/threonine-protein kinase 24	0	0	5	5
Casein kinase I isoform gamma-3	0	0	5	5
Mitogen-activated protein kinase kinase kinase 4	0	0	5	5
Lysine-specific demethylase 4E	0	4	0	4
Lysine-specific histone demethylase 1A	0	14	0	14
Progesterone receptor	0	21	9	33
Fructose-1,6-bisphosphatase 1	0	1	0	1
Lysosomal alpha-glucosidase	0	2	0	2
Polyunsaturated fatty acid 5-lipoxygenase	0	5	0	9
Sucrase-isomaltase, intestinal	0	2	0	2
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Sucrase-isomaltase, intestinal	0	4	0	4
Sodium- and chloride-dependent GABA transporter 1	0	3	0	3
Sodium- and chloride-dependent GABA transporter 2	0	3	0	3
Sodium- and chloride-dependent GABA transporter 3	0	3	0	3
5-hydroxytryptamine receptor 7	0	5	1	6
Prostaglandin G/H synthase 2	0	5	0	7
Linoleate 9S-lipoxygenase-4	0	1	0	1
1-deoxy-D-xylulose 5-phosphate reductoisomerase	0	4	0	4
Sodium- and chloride-dependent betaine transporter	0	3	0	3
Prolyl endopeptidase	0	5	0	5
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	1
Lactoylglutathione lyase	0	10	0	10
Receptor-type tyrosine-protein phosphatase S	0	1	0	1
Prostaglandin G/H synthase 1	0	6	0	8
Polyunsaturated fatty acid lipoxygenase ALOX15B	0	1	0	1
G-protein coupled receptor 35	0	6	5	11
Canalicular multispecific organic anion transporter 1	0	4	0	6
Cathepsin S	0	2	0	2
Sterol O-acyltransferase 1	0	2	0	2
Cathepsin D	0	2	0	2
Cathepsin S	0	6	1	7
Cathepsin K	0	7	0	7
Cathepsin K	0	5	0	5
pyruvate kinase PKM isoform a	3	0	0	3
Telomerase reverse transcriptase	0	1	0	1
Neuraminidase	0	2	0	2
Neuraminidase	0	4	0	4
Tyrosine-protein phosphatase non-receptor type 1	0	19	1	23
Aldo-keto reductase family 1 member C3	0	9	0	9
Aldo-keto reductase family 1 member C2	0	6	0	6
Cholinesterase	0	9	0	9
Cytochrome P450 2B4	0	1	0	1
Cytochrome P450 2E1	0	3	0	3
Cytochrome P450 2B6	0	7	1	8
Cytochrome P450 3A5	0	3	1	5
core protein, partial	0	1	0	1
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent GABA transporter 2	0	2	0	2
Sodium- and chloride-dependent GABA transporter 3	0	2	0	2
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 3	0	1	0	1
Glutamate receptor ionotropic, NMDA 2A	0	12	2	20
Glutamate receptor ionotropic, NMDA 2B	0	12	2	20
Glutamate receptor ionotropic, NMDA 2C	0	12	2	20
Glutamate receptor ionotropic, NMDA 2D	0	12	2	20
Glutamate receptor ionotropic, NMDA 3B	0	12	2	20
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Glutamate receptor ionotropic, NMDA 3A	0	12	2	20
Chain A, D-MALTODEXTRIN BINDING PROTEIN	0	0	1	1
Chain A, Limit Dextrinase	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain B, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, Alpha-hemolysin	0	0	1	1
Chain B, Alpha-hemolysin	0	0	1	1
Chain C, Alpha-hemolysin	0	0	1	1
Chain D, Alpha-hemolysin	0	0	1	1
Chain E, Alpha-hemolysin	0	0	1	1
Chain F, Alpha-hemolysin	0	0	1	1
Chain G, Alpha-hemolysin	0	0	1	1
Progesterone receptor	0	2	0	2
Glucocorticoid receptor	0	4	2	7
Androgen receptor	0	2	2	4
Progesterone receptor	0	2	1	3
Caspase-7	6	0	0	6
STAT3, partial	0	0	2	2
P53	6	0	0	6
ras-related protein Rab-9A	15	0	0	15
signal transducer and activator of transcription 1-alpha/beta isoform alpha	0	0	2	2
transcription factor p65 isoform 1	0	0	2	2
Estrogen receptor beta	0	0	2	4
Pancreatic triacylglycerol lipase	0	9	0	10
Triosephosphate isomerase	0	3	0	3
Carbonyl reductase [NADPH] 1	0	8	0	8
Estrogen receptor	0	0	2	4
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	7	0	7
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
GALC protein	13	0	0	13
GTPase KRas	0	0	1	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	6	0	6
Estrogen-related receptor gamma	0	2	1	3
GTP-binding protein Rheb	0	0	1	1
TSHR protein	1	0	0	1
Solute carrier family 12 member 2	0	1	0	1
Potassium channel subfamily K member 3	0	2	0	2
Potassium channel subfamily K member 3	0	1	0	1
Potassium channel subfamily K member 9	0	1	0	1
Kappa-type opioid receptor	0	11	2	15
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
atrial natriuretic peptide receptor 1 precursor	4	0	0	4
DNA polymerase beta	21	0	0	21
Glycogen phosphorylase, muscle form	0	5	0	5
Renin	0	3	0	3
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	7	1	9
Vasopressin V2 receptor	0	0	0	1
Adenosine receptor A2a	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	4	0	4
Adenylate cyclase type 1	0	0	0	1
Chitotriosidase-1	0	1	0	1
Adenosine receptor A2b	0	1	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	4	0	4
Palmitoleoyl-protein carboxylesterase NOTUM	0	2	2	4
Endochitinase B1	0	1	0	1
Muscarinic acetylcholine receptor	0	5	1	7
Phosphodiesterase	0	4	0	4
Guanine deaminase	0	2	0	3
Chain A, Vitamin D Nuclear Receptor	0	0	1	1
Vitamin D3 receptor	0	0	1	1
Vitamin D-binding protein	0	0	1	1
Vitamin D3 receptor	0	3	4	11
Vitamin D3 receptor	0	1	1	3
Retinoic acid receptor RXR-alpha	0	3	5	8
Cytochrome P450 2C19	0	22	1	25
Vitamin D3 receptor	0	0	2	2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	0	1	1
Vitamin D3 receptor	0	1	1	2
Transporter	0	3	0	3
Vitamin D3 receptor A	0	0	2	2
transient receptor potential cation channel subfamily V member 1	2	0	0	2
NADH-ubiquinone oxidoreductase chain 1	0	1	0	1
Cannabinoid receptor 1	0	7	2	13
Cannabinoid receptor 2	0	4	1	8
D(2) dopamine receptor	0	6	2	8
Potassium voltage-gated channel subfamily A member 1	0	2	1	3
Corticotropin-releasing factor receptor 2	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	0	1	1
Chain A, angiotensin converting enzyme	0	1	0	1
Chain A, angiotensin converting enzyme	0	1	0	1
Metallo-beta-lactamase type 2	0	1	1	3
Prothrombin	0	4	5	10
Neprilysin	0	1	0	1
Neprilysin	0	1	0	1
Leukotriene A-4 hydrolase	0	4	1	5
EEF1AKMT4-ECE2 readthrough transcript protein	0	1	0	1
Angiotensin-converting enzyme	0	6	1	7
Leukotriene A-4 hydrolase	0	1	0	1
Thymidine phosphorylase	0	0	1	2
Endothelin-converting enzyme 1	0	1	0	1
Succinyl-diaminopimelate desuccinylase	0	2	0	2
Angiotensin-converting enzyme	0	2	1	3
Solute carrier family 15 member 1	0	2	0	2
Beta-lactamase TEM	0	2	0	2
Beta-lactamase	0	3	0	4
Beta-lactamase	0	3	0	3
Angiotensin-converting enzyme 2	0	4	11	15
Beta-lactamase class B VIM-2	0	1	1	3
Major prion protein	0	0	4	4
Sodium channel protein type 1 subunit alpha	0	4	0	4
Sodium channel protein type 2 subunit alpha	0	3	0	3
Sodium channel protein type 3 subunit alpha	0	3	0	3
UDP-glucuronosyltransferase 2B7	0	4	0	11
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	1	0	1
Vasopressin V2 receptor	0	2	2	4
Oxytocin receptor	0	3	3	6
Vasopressin V1a receptor	0	8	3	11
Vasopressin V1b receptor	0	1	2	3
Oxytocin receptor	0	0	2	2
Lactoperoxidase	0	2	0	2
Carbonic anhydrase	0	10	0	15
histone-lysine N-methyltransferase 2A isoform 2 precursor	16	0	0	16
Chain A, serum paraoxonase	0	1	0	1
Neutrophil cytosol factor 1	0	1	0	1
Carbonic anhydrase 13	0	4	1	8
Solute carrier family 15 member 2	0	2	0	2
Solute carrier family 15 member 2	0	2	0	2
Arginase	0	5	0	6
Melatonin receptor type 1A	0	2	2	4
Melatonin receptor type 1B	0	2	2	4
Dihydroorotate dehydrogenase	0	4	0	4
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-11	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-2	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-19	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	1	0	1
Albumin	0	7	7	18
Beta-lactamase SHV-1	0	0	0	1
Beta-lactamase SHV-1	0	0	0	1
Beta-lactamase	0	0	0	1
Solute carrier family 15 member 1	0	1	0	1
B2 metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-13	0	1	0	2
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-beta-lactamase VIM-2	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase Toho-1	0	0	0	1
Beta-lactamase	0	0	0	1
Solute carrier family 22 member 6	0	9	0	13
Solute carrier family 22 member 7	0	2	0	5
Metallo-beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Metallo-b-lactamase	0	0	0	1
BlaVIM-1	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Solute carrier family 22 member 8	0	8	0	13
Beta-lactamase	0	0	0	1
Carbapenem-hydrolyzing beta-lactamase KPC	0	0	0	1
Histamine H3 receptor	0	2	1	4
Solute carrier family 22 member 11	0	3	0	8
Solute carrier family 22 member 8	0	6	0	8
Beta-lactamase VIM-1	0	1	0	2
Solute carrier family 22 member 7	0	2	0	4
Nuclear receptor subfamily 4 group A member 1	0	0	1	1
Monoglyceride lipase	0	1	0	1
thyrotropin-releasing hormone receptor	13	0	0	13
Caspase-2	0	0	1	1
FAD-linked sulfhydryl oxidase ALR	0	0	0	2
Chain A, BCL-2-RELATED PROTEIN A1	0	0	2	2
PAX8	0	0	0	2
PINK1	8	0	0	8
heat shock protein 90	0	0	1	1
calcineurin A1, putative	0	0	1	1
hepatocyte nuclear factor 4-alpha isoform 2	0	3	0	3
perilipin-5	0	5	0	5
perilipin-1	0	5	0	5
transcriptional regulator ERG isoform 3	11	0	0	11
ubiquitin-conjugating enzyme E2 N	0	4	0	4
protein AF-9 isoform a	0	0	0	2
melanocortin receptor 4	0	1	0	1
CAAX prenyl protease	0	0	0	1
bcl-2-related protein A1	0	3	0	3
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	5	0	5
glycogen synthase kinase-3 alpha	0	0	0	4
hexokinase HKDC1	0	1	0	1
DNA repair protein RAD52 homolog isoform a	0	0	0	2
bcl-2-like protein 11 isoform 1	0	0	2	2
Synaptojanin-2	0	1	0	1
Solute carrier family 22 member 2	0	9	0	13
Synaptojanin-1	0	1	0	1
Solute carrier family 22 member 3	0	9	0	10
Glutathione reductase, mitochondrial	0	9	0	10
72 kDa type IV collagenase	0	8	0	8
Matrix metalloproteinase-9	0	7	0	7
Trypanothione reductase	0	4	0	6
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	0	1	0	1
Multidrug and toxin extrusion protein 2	0	6	0	6
Rap guanine nucleotide exchange factor 4	12	0	0	12
Multidrug and toxin extrusion protein 1	0	15	0	15
Spermine oxidase	0	1	0	1
1,3-beta-D-glucan synthase catalytic subunit	0	1	0	1
Tyrosine-protein phosphatase non-receptor type 2	0	4	0	4
large T antigen	0	5	1	6
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase	0	1	0	1
Spike glycoprotein	0	2	11	13
glucose-6-phosphate 1-dehydrogenase isoform b	0	1	0	1
Transmembrane protease serine 2	0	2	11	13
Dihydrofolate reductase	0	2	0	2
DNA ligase	0	1	0	1
Riboflavin-binding protein	0	1	2	3
Histidine-rich protein PFHRP-II	0	2	0	3
Spike glycoprotein	0	1	0	1
DNA ligase 1	0	1	0	1
Calcium-dependent protein kinase 1	0	0	1	1
DNA ligase A	0	1	0	1
Sigma intracellular receptor 2	0	2	0	2
Phosphoethanolamine N-methyltransferase	0	1	0	1
Cysteine proteinase falcipain 2a	0	1	0	1
Cysteine proteinase falcipain 2a	0	1	0	1
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7	0	0	0	4
Glycine receptor subunit alpha-1	0	0	5	5
Chain A, Glycogen phosphorylase, muscle form	0	1	0	1
Chain A, Glycogen phosphorylase, muscle form	0	1	0	1
Nrf2	4	0	0	4
nuclear receptor subfamily 0 group B member 1	0	2	0	2
steroidogenic factor 1	0	2	0	2
Cytochrome P450 2A6	0	7	2	10
Aldo-keto reductase family 1 member B1	0	6	0	6
3-oxoacyl-acyl-carrier protein reductase	0	5	0	5
P2Y purinoceptor 12	0	2	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	5	0	6
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	5	0	6
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	6	0	7
Glutamine synthetase	0	1	0	1
Solute carrier family 22 member 1	0	1	0	1
Solute carrier family 22 member 2	0	1	0	1
ATP-dependent translocase ABCB1	0	5	0	5
Potassium-transporting ATPase alpha chain 1	0	2	0	2
ATP-dependent translocase ABCB1	0	6	2	8
Histamine H1 receptor	0	1	4	5
Potassium-transporting ATPase subunit beta	0	2	0	2
Aldehyde oxidase	0	6	0	7
Solute carrier family 22 member 1	0	8	0	10
Histamine H4 receptor	0	5	2	7
Solute carrier family 22 member 2	0	7	0	8
Solute carrier family 22 member 4	0	1	0	1
Extracellular calcium-sensing receptor	0	1	1	2
Sodium-dependent noradrenaline transporter	0	3	0	3
Tryptophan 5-hydroxylase 1	0	3	0	3
Aromatase	0	1	0	1
Sodium-dependent dopamine transporter	0	10	1	11
Sigma intracellular receptor 2	0	5	0	5
Sodium-dependent serotonin transporter	0	3	0	3
Sodium-dependent dopamine transporter	0	5	0	5
Transporter	0	9	1	11
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	1	0	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Beta-lactamase	0	1	0	1
3-dehydroquinate dehydratase	0	0	1	1
ATP-citrate synthase	0	1	0	2
Ribonuclease T	0	0	0	1
Cell death-related nuclease 4	0	0	0	1
3-dehydroquinate dehydratase	0	0	1	1
Prolyl 4-hydroxylase	0	5	0	5
Alpha-ketoglutarate-dependent dioxygenase FTO	0	3	0	3
Protein-arginine deiminase type-4	0	5	0	5
Type IV secretion-like conjugative transfer relaxase protein TraI	0	2	0	2
Stromelysin-1	0	6	1	7
Macrophage metalloelastase	0	3	0	3
Beta-1 adrenergic receptor	0	1	3	5
Alpha-1B adrenergic receptor	0	0	2	2
Membrane primary amine oxidase	0	1	0	1
5-hydroxytryptamine receptor 3A	0	0	1	1
5-hydroxytryptamine receptor 1A	0	3	1	4
Alpha-1B adrenergic receptor	0	39	1	40
Alpha-1A adrenergic receptor	0	2	2	4
D	0	4	0	4
Alpha-1D adrenergic receptor	0	14	1	15
D(1B) dopamine receptor	0	3	0	3
Alpha-2B adrenergic receptor	0	1	0	2
D(4) dopamine receptor	0	3	0	3
Delta-type opioid receptor	0	13	1	16
Alpha-2C adrenergic receptor	0	1	0	2
Alpha-2A adrenergic receptor	0	1	0	2
Alpha-2A adrenergic receptor	0	2	0	2
Nischarin	0	4	0	4
Nischarin	0	3	0	3
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	0	1
Liver carboxylesterase 1	0	5	0	6
Lysosomal Pro-X carboxypeptidase	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	6	1	8
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	6	1	8
Leukotriene B4 receptor 1	0	1	0	2
Leukotriene B4 receptor 2	0	1	1	3
Tubulin beta-4A chain	0	3	3	8
Tubulin beta chain	0	3	3	8
Tubulin alpha-3C chain	0	3	3	8
Tubulin alpha-1B chain	0	3	3	8
Tubulin alpha-4A chain	0	3	3	8
Tubulin beta-4B chain	0	3	3	8
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	4	3	9
Tubulin beta-2A chain	0	3	3	8
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	3	3	8
Tubulin alpha-3E chain	0	3	3	8
Tubulin alpha-1A chain	0	3	3	8
CREB-binding protein	2	1	0	3
Tubulin alpha-1C chain	0	3	3	8
Tubulin beta-6 chain	0	3	3	8
Tubulin beta-2B chain	0	3	3	8
Tubulin beta-1 chain	0	3	3	8
Solute carrier family 22 member 3	0	1	0	1
C-8 sterol isomerase	0	4	0	4
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	5	1	6
Glycine receptor subunit alpha-1	0	34	0	34
Glycine receptor subunit beta	0	34	0	34
Glycine receptor subunit alpha-2	0	34	0	34
Glycine receptor subunit alpha-3	0	34	0	34
Cytochrome P450 2A5	0	2	0	3
Exportin-1	0	2	0	2
NAD-dependent histone deacetylase SIR2	0	1	0	3
Amine oxidase [flavin-containing] B	0	4	0	4
Acetylcholinesterase	0	2	0	2
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal	0	2	0	2
UDP-glucuronosyltransferase 2B10	0	3	0	3
Quinone oxidoreductase	0	0	0	3
Sorbitol dehydrogenase	0	2	0	2
Zn finger protein	0	1	0	1
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Membrane-associated progesterone receptor component 1	0	0	1	1
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	0	1	0	1
Sodium-dependent phosphate transport protein 2B	0	1	0	1
Tyrosine-protein kinase ABL1	0	1	0	1
HLA class II histocompatibility antigen gamma chain	0	1	0	1
Nucleophosmin	0	1	0	1
ALK tyrosine kinase receptor	0	1	0	1
Angiopoietin-1 receptor	0	1	0	1
Lysine--tRNA ligase	0	1	0	1
Cyclin-dependent kinase 10	0	0	2	2
Uncharacterized aarF domain-containing protein kinase 5	0	0	3	3
Rab-like protein 3	0	0	2	2
Macrophage-stimulating protein receptor	0	1	0	1
Mixed lineage kinase domain-like protein	0	0	1	1
Dual specificity testis-specific protein kinase 2	0	0	2	2
Echinoderm microtubule-associated protein-like 4	0	1	0	1
Isoleucine--tRNA ligase, mitochondrial	0	0	3	3
Aurora kinase A-interacting protein	0	1	0	1
isocitrate dehydrogenase 1, partial	4	0	0	4
streptokinase A precursor	0	0	7	7
Cocaine esterase	0	3	0	3
Papain	0	1	0	1
Estrogen receptor	0	4	6	11
Receptor-type tyrosine-protein phosphatase C	0	2	0	2
Receptor-type tyrosine-protein phosphatase F	0	3	0	3
Indoleamine 2,3-dioxygenase 1	0	4	1	6
Tyrosine-protein phosphatase non-receptor type 6	0	4	0	4
Tyrosine-protein phosphatase non-receptor type 9	0	1	0	1
Tryptophan 2,3-dioxygenase	0	2	0	3
Tyrosine-protein phosphatase non-receptor type 11	0	3	0	4
Hypoxia-inducible factor 1-alpha	0	4	0	4
Estrogen receptor beta	0	3	6	10
Endothelial PAS domain-containing protein 1	0	3	0	3
Protease	0	8	3	11
Chain A, Breast cancer type 1 susceptibility protein	2	0	0	2
alkaline phosphatase, intestinal	0	1	0	1
toll-like receptor 9	0	1	0	1
TPA: protein transporter TIM10	0	1	0	1
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	1	0	1
intestinal alkaline phosphatase precursor	0	1	0	1
alkaline phosphatase, germ cell type preproprotein	0	1	0	1
hypothetical protein SA1422	0	1	0	1
DNA dC->dU-editing enzyme APOBEC-3F isoform a	1	0	0	1
Prostaglandin E synthase	0	2	0	2
D-amino-acid oxidase	0	1	0	1
Phospholipase A2	0	3	0	3
Neuronal proto-oncogene tyrosine-protein kinase Src	0	1	0	1
Heme oxygenase 1	0	1	0	1
Glutathione S-transferase P	0	2	0	2
Microtubule-associated protein tau	0	2	0	3
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Aminopeptidase N	0	1	0	1
Aminopeptidase N	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	2	0	2
Heme oxygenase 2	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	3	0	3
Voltage-dependent L-type calcium channel subunit alpha-1S	0	3	0	3
5-hydroxytryptamine receptor 4	0	0	1	1
Sodium/bile acid cotransporter	0	7	1	9
Nuclear factor erythroid 2-related factor 2	0	0	3	5
Thioredoxin reductase 1, cytoplasmic	0	1	0	1
Thioredoxin reductase 3	0	1	0	1
Sortase A	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	0	2	0	2
Thioredoxin reductase 2, mitochondrial	0	1	0	1
CDGSH iron-sulfur domain-containing protein 1	0	8	0	8
Lymphocyte antigen 96	0	0	1	1
Beta lactamase (plasmid)	0	1	0	1
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	0	4	0	4
Oxysterols receptor LXR-beta	0	1	2	3
Oxysterols receptor LXR-alpha	0	1	2	3
Phosphodiesterase	0	2	0	2
Multidrug resistance-associated protein 5	0	0	0	1
RPL19A	0	0	1	1
heat shock protein HSP 90-alpha isoform 2	0	2	0	4
transactivating tegument protein VP16 [Human herpesvirus 1]	0	4	0	4
COUP transcription factor 2 isoform a	0	1	0	1
Glucose transporter	0	1	0	1
Hexose transporter 1	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 1	0	3	0	3
Eukaryotic initiation factor 4A-I	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	6	2	8
Peptidyl-prolyl cis-trans isomerase FKBP3	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP4	0	1	0	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	3	1	4
Peptidyl-prolyl cis-trans isomerase FKBP14	0	1	0	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	0	1	0	1
heat shock protein 90, putative	0	0	0	2
ORF73	0	0	1	1
Deoxycytidine kinase	0	0	0	1
Alpha-tocopherol transfer protein	0	0	1	1
rac GTPase-activating protein 1 isoform a	0	1	0	1
Aldehyde dehydrogenase, mitochondrial	0	1	0	1
Tyrosinase	0	6	0	6
Beta-3 adrenergic receptor	0	12	2	14
Substance-K receptor	0	20	0	20
exodeoxyribonuclease V subunit RecD	0	1	0	1
exodeoxyribonuclease V subunit RecB	0	1	0	1
exodeoxyribonuclease V subunit RecC	0	1	0	1
DNA (cytosine-5)-methyltransferase 1	0	2	0	2
Histone-lysine N-methyltransferase EHMT2	0	1	0	1
Beta-glucuronidase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
NPC1-like intracellular cholesterol transporter 1	0	1	1	2
Solute carrier organic anion transporter family member 1A4	0	4	0	10
Solute carrier organic anion transporter family member 1A5	0	0	0	6
Steryl-sulfatase	0	5	0	7
Solute carrier organic anion transporter family member 1A2	0	0	0	5
Solute carrier organic anion transporter family member 1A3	0	3	0	8
ATP-binding cassette sub-family C member 11	0	0	0	2
Solute carrier organic anion transporter family member 1A1	0	0	0	3
Solute carrier organic anion transporter family member 1B2	0	1	0	5
hexokinase-4 isoform 1	5	0	0	5
glucokinase regulatory protein	5	0	0	5
Chain A, STEROID DELTA-ISOMERASE	0	0	1	1
Steroid Delta-isomerase	0	0	1	1
Ileal sodium/bile acid cotransporter	0	2	0	3
Thymidine kinase 2	0	1	0	1
Probable deoxycytidylate deaminase	0	0	0	1
Cytidine deaminase	0	0	0	2
AAA family ATPase	0	0	0	2
Thymidine kinase, cytosolic	0	3	0	6
AAA family ATPase	0	0	0	1
Sterol O-acyltransferase 1	0	2	0	2
Nuclear receptor subfamily 1 group I member 2	0	1	12	13
Beta-1 adrenergic receptor	0	8	2	10
Thromboxane-A synthase	0	9	0	9
UDP-glucose 4-epimerase	0	1	0	1
Cysteinyl leukotriene receptor 1	0	4	1	5
Chain A, Sex Hormone-Binding Globulin	0	0	1	1
Sex hormone-binding globulin	0	1	0	1
Cannabinoid receptor 2	0	2	2	4
Neuropeptide FF receptor 2	0	0	0	2
prostaglandin E2 receptor EP2 subtype	1	0	0	1
Prostaglandin E2 receptor EP3 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	2	0	2
Prostaglandin E2 receptor EP1 subtype	0	2	1	3
Prostaglandin E2 receptor EP1 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	2	1	3
Prostaglandin F2-alpha receptor	0	0	1	1
Prostaglandin E2 receptor EP4 subtype	0	1	1	2
Prostaglandin E2 receptor EP3 subtype	0	2	1	3
Prostaglandin E2 receptor EP2 subtype	0	2	1	3
Prostacyclin receptor	0	2	1	3
Prostaglandin E2 receptor EP2 subtype	0	2	0	2
Prostaglandin E2 receptor EP2 subtype	0	1	1	2
Solute carrier family 22 member 7	0	0	0	2
Solute carrier organic anion transporter family member 2A1	0	1	0	2
Serum paraoxonase/arylesterase 1	0	5	0	5
Kinesin-like protein KIF11	0	1	0	1
Nucleotide-binding oligomerization domain-containing protein 2	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	1	0	1
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase	0	1	0	1
Eyes absent homolog 2	0	2	0	2
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))	0	1	0	1
Oxoeicosanoid receptor 1	0	1	0	1
chaperonin-containing TCP-1 beta subunit homolog	4	0	0	4
Endothelin-1 receptor	0	2	1	3
Capsid protein	0	0	1	1
Genome polyprotein	0	4	1	5
eyes absent homolog 2 isoform a	4	0	0	4
relaxin receptor 1 isoform 1	1	0	0	1
Flavin reductase (NADPH)	0	0	2	2
Lanosterol 14-alpha demethylase	0	0	1	1
Olfactory receptor 51E2	0	0	2	2
UDP-glucuronosyltransferase 1A10	0	0	0	1
Mu-type opioid receptor	0	14	5	23
Ghrelin O-acyltransferase	0	2	0	2
Sodium/bile acid cotransporter	0	1	0	3
Solute carrier organic anion transporter family member	0	0	0	2
Solute carrier organic anion transporter family member 1C1	0	3	0	3
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	3	0	3
Sulfotransferase 1A1	0	2	1	4
Nuclear receptor subfamily 1 group I member 3	0	1	0	1
Renin	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
ClpP	7	0	0	7
LMP1 [Human herpesvirus 4]	0	0	0	1
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	0	2	0	2
nuclear receptor coactivator 3 isoform a	0	2	0	2
Regulatory protein E2	0	0	1	1
DNA topoisomerase 1	0	3	0	7
DNA topoisomerase 2	0	0	0	1
Caspase-3	0	4	0	4
DNA topoisomerase 2-alpha	0	0	0	1
NPC1-like intracellular cholesterol transporter 1	0	1	0	1
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Cytochrome P450 11B2, mitochondrial	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	2	0	2
Cytochrome P450 11B2, mitochondrial	0	1	0	1
Protein farnesyltransferase subunit beta	0	0	0	1
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	0	0	0	1
Squalene synthase	0	0	0	1
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	0	0	1	2
Protein farnesyltransferase subunit beta	0	0	1	2
Squalene synthase	0	3	0	4
Geranylgeranyl pyrophosphate synthase	0	4	0	5
Cathepsin B	0	1	0	1
procathepsin L isoform 1 preproprotein	0	2	0	2
fructose-bisphosphate aldolase	0	1	0	1
Nuclear receptor subfamily 1 group I member 2	0	0	3	3
Fatty acid-binding protein, liver	0	1	1	2
Peroxisome proliferator-activated receptor alpha	0	2	3	5
Cruzipain	0	8	0	8
Peroxisome proliferator-activated receptor alpha	0	0	1	1
D(4) dopamine receptor	0	6	0	6
Delta-type opioid receptor	0	12	3	17
Kappa-type opioid receptor	0	5	3	9
Mu-type opioid receptor	0	4	1	8
Alpha-glucosidase MAL12	0	3	0	3
Carbonic anhydrase 2	0	4	0	4
Hyaluronidase-1	0	1	0	1
Chain B, Cell division protein kinase 6	0	1	0	1
Alpha-amylase 1A	0	3	0	3
Chain A, PROTEIN (TRANSTHYRETIN)	0	0	1	1
Chain B, PROTEIN (TRANSTHYRETIN)	0	0	1	1
Transient receptor potential cation channel subfamily M member 2	0	1	0	1
Cytochrome c oxidase subunit 2	0	3	0	3
Aldo-keto reductase family 1 member C4	0	4	0	4
Transcription factor SOX-18	0	1	0	1
Aldo-keto reductase family 1 member C1	0	5	0	5
Transcriptional enhancer factor TEF-3	0	1	1	2
Potassium channel subfamily K member 18	0	1	1	2
Acid-sensing ion channel 5	0	0	1	1
Chain A, Uracil Phosphoribosyltransferase	0	1	0	1
Skn7p	0	0	0	1
Solute carrier family 22 member 8	0	0	0	1
Thymidylate synthase	0	5	0	6
Cytochrome P450 2C8	0	7	0	8
Dipeptidyl peptidase 4	0	2	0	2
Potassium voltage-gated channel subfamily C member 1	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	1	0	1
Beta-2 adrenergic receptor	0	4	2	8
Acid-sensing ion channel 3	0	2	0	2
Acid-sensing ion channel 1	0	2	0	2
Prostaglandin G/H synthase 2	0	3	0	4
Chain A, Dihydrofolate reductase	0	0	1	1
Thymidylate synthase	0	6	0	6
Dihydrofolate reductase	0	3	3	6
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Multidrug resistance associated protein	0	2	0	5
Coagulation factor X	0	1	0	1
Interleukin-2	0	0	1	1
Amine oxidase [flavin-containing] A	0	1	0	1
Amine oxidase [flavin-containing] B	0	1	0	1
Steroid hormone receptor ERR1	0	3	0	3
Bifunctional epoxide hydrolase 2	0	9	0	9
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	3	0	3
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	3	1	4
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	2	1	3
6-phosphogluconate dehydrogenase, decarboxylating	0	3	0	3
Holo-[acyl-carrier-protein] synthase	0	1	0	1
Beta-galactosidase	0	1	0	1
Lipopolysaccharide heptosyltransferase 1	0	1	0	1
PA-I galactophilic lectin	0	0	1	1
Jacalin	0	0	1	1
fructose-bisphosphate aldolase A	1	0	0	1
glyceraldehyde-3-phosphate dehydrogenase isoform 1	1	0	0	1
Urokinase-type plasminogen activator	0	2	0	2
Tissue-type plasminogen activator	0	1	0	1
Plasminogen activator inhibitor 1	0	1	0	1
Urokinase-type plasminogen activator	0	1	0	1
Matrilysin	0	2	0	2
L-selectin	0	1	0	1
P-selectin	0	1	0	1
E-selectin	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	2	0	2
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6	0	1	0	1
Squalene monooxygenase	0	1	0	1
Autoinducer 2-binding periplasmic protein LuxP	0	1	0	1
Anthrax toxin receptor 2	0	2	0	2
Polypeptide N-acetylgalactosaminyltransferase 2	0	1	1	2
Alpha-(1,3)-fucosyltransferase 7	0	1	0	1
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	0	1	0	1
Carbonic anhydrase	0	2	0	2
Toll-like receptor 2	0	1	0	1
Caspase 6, apoptosis-related cysteine peptidase	0	0	0	1
Free fatty acid receptor 1	0	0	4	4
epidermal growth factor receptor isoform a precursor	1	1	0	2
Quinolone resistance protein NorA	0	1	0	1
Myosin light chain kinase, smooth muscle	0	0	1	1
Mitogen-activated protein kinase kinase kinase 8	0	1	0	1
Tubulin alpha-1A chain	0	0	1	1
Synaptic vesicular amine transporter	0	1	0	1
Transcription factor p65	0	8	0	8
Serine/threonine-protein kinase ULK3	0	0	1	1
Chain A, DEOXYNUCLEOSIDE KINASE	0	1	0	1
Chain A, Estrogen receptor 1 (alpha)	0	1	0	1
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
Alpha-mannosidase	0	1	0	1
Maltase-glucoamylase, intestinal	0	3	0	3
Steroid hormone receptor ERR2	0	1	0	1
Ornithine decarboxylase	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
Amine oxidase [flavin-containing] A	0	2	0	2
G1/S-specific cyclin-D1	0	2	0	2
Cystic fibrosis transmembrane conductance regulator	0	0	1	1
Alpha-glucosidase MAL32	0	1	0	1
Amine oxidase [flavin-containing] B	0	2	0	2
Tissue alpha-L-fucosidase	0	1	0	1
DNA (cytosine-5)-methyltransferase 3-like	0	1	0	1
DNA (cytosine-5)-methyltransferase 3A	0	1	0	1
Glucagon-like peptide 1 receptor	0	0	1	1
Glucagon-like peptide 1 receptor	0	1	1	2
Glucagon receptor	0	0	1	1
Glucagon receptor	0	0	1	1
Asialoglycoprotein receptor 1	0	1	1	2
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
beta-2 adrenergic receptor	3	0	0	3
Metabotropic glutamate receptor 8	0	2	0	2
Metabotropic glutamate receptor 6	0	1	1	3
Glutamate receptor ionotropic, NMDA 2D	0	3	1	4
Excitatory amino acid transporter 4	0	1	0	1
Glutamate receptor ionotropic, NMDA 3B	0	3	1	4
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
Glutamate receptor ionotropic, kainate 1	0	2	1	3
Metabotropic glutamate receptor 1	0	2	1	3
Metabotropic glutamate receptor 2	0	0	1	1
Metabotropic glutamate receptor 3	0	0	1	1
Metabotropic glutamate receptor 4	0	1	1	2
Metabotropic glutamate receptor 5	0	1	2	3
Metabotropic glutamate receptor 6	0	0	1	1
Metabotropic glutamate receptor 7	0	0	1	1
Glutamate receptor ionotropic, kainate 1	0	1	1	2
Metabotropic glutamate receptor 5	0	1	1	3
Glutamate receptor ionotropic, kainate 2	0	2	1	3
Glutamate receptor 1	0	2	1	3
Glutamate receptor 2	0	2	1	3
Glutamate receptor 3	0	1	1	2
Glutamate receptor ionotropic, kainate 3	0	2	0	2
Excitatory amino acid transporter 1	0	2	0	3
Excitatory amino acid transporter 2	0	2	0	3
Excitatory amino acid transporter 3	0	2	0	3
Metabotropic glutamate receptor 8	0	0	1	1
Glutamate receptor 4	0	2	1	3
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	1	1	2
Fatty-acid amide hydrolase 1	0	3	0	3
Glutamate receptor ionotropic, kainate 4	0	2	0	2
Glutamate carboxypeptidase 2	0	1	0	1
Glutamate receptor ionotropic, NMDA 1	0	5	1	6
Glutamate receptor ionotropic, NMDA 2A	0	5	1	6
Glutamate receptor ionotropic, kainate 2	0	1	1	2
Glutamate receptor ionotropic, kainate 3	0	1	0	1
Glutamate receptor ionotropic, NMDA 2B	0	5	1	6
Metabotropic glutamate receptor 1	0	1	1	3
Metabotropic glutamate receptor 2	0	1	1	3
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	1	1	3
Glutamate receptor ionotropic, NMDA 2C	0	3	1	4
Glutamate receptor ionotropic, kainate 5	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	2	0	2
Glutamate racemase	0	0	0	1
Glutamate receptor ionotropic, NMDA 3A	0	3	1	4
Chain A, Protein (aspartate Aminotransferase)	0	0	2	2
Chain A, Aspartate Aminotransferase	0	0	2	2
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E	0	0	1	1
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	6	0	7
Serine racemase	0	1	0	1
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
Pancreatic alpha-amylase	0	3	0	5
High mobility group protein B1	0	0	3	3
High mobility group protein B1	0	0	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 2	0	1	1	2
Hypoxanthine-guanine phosphoribosyltransferase	0	0	0	1
Ricin	0	1	0	1
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	0	0	1	1
Purine nucleoside phosphorylase	0	0	1	2
Shiga toxin subunit A	0	1	0	1
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	2	0	2
Heparanase	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Protein (female-specific Histamine Binding Protein 2)	0	0	1	1
aryl hydrocarbon receptor nuclear translocator	0	0	0	1
transforming acidic coiled-coil-containing protein 3	0	0	0	1
Macrophage migration inhibitory factor	0	4	0	4
Carbonic anhydrase	0	2	0	8
Histamine H3 receptor	0	2	0	2
Histamine N-methyltransferase	0	1	0	1
Glutaminyl-peptide cyclotransferase	0	2	0	2
Carbonic anhydrase	0	2	0	8
Carbonic anhydrase	0	2	0	8
Equilibrative nucleoside transporter 4	0	0	0	1
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	0	1
Chain A, HISTIDINE-BINDING PROTEIN	0	0	1	1
Histidine-binding periplasmic protein	0	0	1	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	6	0	7
Carbonic anhydrase	0	4	0	4
Hsf1 protein	0	0	1	1
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase, alpha family	0	4	0	4
Carbonic anhydrase	0	3	0	3
Delta carbonic anhydrase	0	3	0	3
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase	0	3	0	3
Transient receptor potential cation channel subfamily A member 1	0	1	1	2
Cyclic GMP-AMP synthase	0	1	0	1
Toll-like receptor 9	0	1	0	1
Toll-like receptor 7	0	1	0	1
Glutamine synthetase	0	1	0	1
Asc-type amino acid transporter 1	0	1	0	1
2-5A-dependent ribonuclease	0	1	0	1
Dihydrofolate reductase	0	9	0	10
Prostaglandin G/H synthase 1	0	2	0	2
Caspase-1	0	4	0	5
Caspase-4	0	3	0	3
Caspase-5	0	3	0	3
Caspase-9	0	3	0	3
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	3	0	3
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	3	0	3
Snq2p	0	0	0	2
Sphingomyelin phosphodiesterase	0	1	0	1
Pleiotropic ABC efflux transporter of multiple drugs	0	2	0	4
5-hydroxytryptamine receptor 2C	0	1	0	1
D(2) dopamine receptor	0	1	0	1
Envelope glycoprotein	0	0	3	3
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, Cell Division Protein Kinase 2	0	1	0	1
DNA repair and recombination protein RadA	0	0	1	1
Cyclin-A1	0	1	0	1
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
3',5'-cyclic-AMP phosphodiesterase	0	3	0	3
Phospholipase A2, major isoenzyme	0	1	0	1
Interleukin-8	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	5	0	5
C-X-C chemokine receptor type 3	0	2	0	2
Prostaglandin D2 receptor	0	2	0	2
Uracil nucleotide/cysteinyl leukotriene receptor	0	3	0	3
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
Chain B, Pulmonary surfactant-associated protein D	0	1	0	1
Chain A, Pulmonary surfactant-associated protein D	0	1	0	1
Sodium/myo-inositol cotransporter 2	0	1	0	1
SUMO-1-specific protease	0	1	0	1
SUMO1/sentrin specific peptidase 7	0	1	0	1
caspase-3 isoform a preproprotein	0	1	0	1
sentrin-specific protease 8	0	1	0	1
Neuronal acetylcholine receptor subunit beta-2	0	3	1	4
Neuronal acetylcholine receptor subunit alpha-7	0	3	2	5
Chymotrypsinogen A	0	4	0	4
Cell division control protein 42 homolog	0	1	0	1
Ras-related C3 botulinum toxin substrate 1	0	1	0	1
Cathepsin B	0	1	0	1
Procathepsin L	0	1	0	1
Procathepsin L	0	1	0	1
Cathepsin B	0	2	0	2
Cathepsin K	0	1	0	1
Chain A, Lectin	0	0	1	1
Chain A, Lectin	0	0	1	1
Chain A, Lectin	0	0	1	1
Chain A, Lectin	0	0	1	1
Chain A, ERYTHRINA CRISTA-GALLI LECTIN	0	0	1	1
Chain A, ERYTHRINA CRISTA-GALLI LECTIN	0	0	1	1
Chain A, cellulase	0	0	1	1
Chain A, cellulase	0	0	1	1
Chain A, Galectin-3	0	0	1	1
Chain A, Anti-tumor lectin	0	1	0	1
Galectin-3	0	1	0	1
Galectin-9	0	0	1	1
Galectin-8	0	0	1	1
Beta-galactoside-binding lectin	0	1	0	1
Galectin-1	0	1	1	3
Galectin-3	0	1	1	2
Galectin-3	0	1	1	3
Galectin-7	0	0	1	1
Alpha 1,4 galactosyltransferase	0	0	0	1
phosphoethanolamine/phosphocholine phosphatase isoform 1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	3	0	3
Sodium/potassium-transporting ATPase subunit beta-1	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-3	0	3	0	3
Sodium/potassium-transporting ATPase subunit beta-2	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-2	0	3	0	3
Sodium/potassium-transporting ATPase subunit beta-3	0	3	0	3
Sodium/potassium-transporting ATPase subunit gamma	0	3	0	3
WD repeat-containing protein 5	0	3	0	3
Histone-lysine N-methyltransferase 2A	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-4	0	3	0	3
Cytosolic endo-beta-N-acetylglucosaminidase	0	3	0	3
Indoleamine 2,3-dioxygenase 2	0	4	0	4
Free fatty acid receptor 4	0	0	1	1
runt-related transcription factor 1 isoform AML1b	2	0	0	2
core-binding factor subunit beta isoform 2	2	0	0	2
Gonadotropin-releasing hormone receptor	0	1	0	1
Gonadotropin-releasing hormone receptor	0	2	0	2
Synaptic vesicle glycoprotein 2A	0	1	0	1
Potassium voltage-gated channel subfamily A member 5	0	2	0	2
Potassium voltage-gated channel subfamily D member 2	0	1	0	1
N-formyl peptide receptor 2	0	1	0	1
Nuclear factor NF-kappa-B p100 subunit	0	5	0	5
Chain A, protease	0	1	0	1
Chain B, protease	0	1	0	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, protease	0	0	1	1
Chain B, protease	0	0	1	1
Chain A, Protease	0	1	0	1
Chain B, Protease	0	1	0	1
Chain A, Protease	0	1	0	1
Chain B, Protease	0	1	0	1
Chain A, Protease	0	1	0	1
Chain B, Protease	0	1	0	1
Chain A, PROTEASE RETROPEPSIN	0	1	0	1
Chain B, PROTEASE RETROPEPSIN	0	1	0	1
Chain A, Protease Retropepsin	0	1	0	1
Chain B, Protease Retropepsin	0	1	0	1
Chain A, Protease Retropepsin	0	1	0	1
Chain B, Protease Retropepsin	0	1	0	1
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Protease	0	4	2	8
CAAX prenyl protease 1 homolog	0	1	0	1
Plasmepsin V	0	2	0	2
Platelet-activating factor receptor	0	1	0	2
Sodium-dependent neutral amino acid transporter B(0)AT2	0	1	0	1
Potassium channel subfamily K member 9	0	1	0	1
Chain A, Antigen Cd11a (p180)	0	1	0	1
Integrin beta-2	0	1	0	1
Intercellular adhesion molecule 1	0	1	0	1
Integrin alpha-L	0	1	1	2
Acyl-CoA:cholesterol acyltransferase	0	1	0	1
Tryptophan 5-hydroxylase 1	0	1	0	1
histidine kinase	0	1	0	1
integrase, partial	0	2	0	2
lens epithelium-derived growth factor p75	0	2	0	2
galactokinase	2	0	0	2
POsterior Segregation	0	0	2	2
Interstitial collagenase	0	3	1	4
Chemotaxis protein CheA	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	3	0	3
Fatty acid synthase	0	2	0	2
Cytosol aminopeptidase	0	2	0	2
Collagenase 3	0	4	0	4
Protein polybromo-1	0	0	1	1
Histone-lysine N-methyltransferase SETD7	0	2	0	2
DNA topoisomerase 1	0	1	0	1
Zinc finger protein mex-5	0	0	2	2
M1-family alanyl aminopeptidase	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Lysophosphatidic acid receptor 6	0	0	1	1
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	0	2	0	2
Lysophosphatidic acid receptor 4	0	0	1	1
Lysophosphatidic acid receptor 1	0	0	2	2
Lysophosphatidic acid receptor 4	0	0	1	1
Lysophosphatidic acid receptor 5	0	0	1	1
Lysophosphatidic acid receptor 2	0	0	1	1
Lysophosphatidic acid receptor 3	0	0	1	1
Alpha-mannosidase 2C1	0	1	0	1
Fucose-binding lectin PA-IIL	0	1	0	1
CD209 antigen	0	1	0	1
Cytochrome P450 1A2	0	1	0	1
Cytochrome P450 2C11	0	1	0	1
Acetylcholinesterase	0	1	0	1
Nociceptin receptor	0	1	0	1
Melatonin receptor type 1C	0	0	1	1
Melatonin receptor type 1A	0	1	1	2
Melatonin receptor type 1C	0	1	1	2
Melatonin receptor type 1B	0	1	1	2
Carboxylic ester hydrolase	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	3	2	6
Neuronal acetylcholine receptor subunit beta-4	0	3	2	6
Neuronal acetylcholine receptor subunit alpha-6	0	3	2	6
Vitamin K-dependent gamma-carboxylase	0	0	0	1
Glutaminyl-peptide cyclotransferase	0	1	0	1
Mas-related G-protein coupled receptor member X2	0	0	3	3
Aldehyde oxidase 1	0	2	0	2
Dopamine beta-hydroxylase	0	2	0	2
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Thymidylate synthase	0	2	0	2
Thymidylate synthase	0	2	0	2
Toll-like receptor 4	0	1	0	1
Fatty-acid amide hydrolase 1	0	1	0	1
ATP-binding cassette sub-family C member 3	0	1	0	3
Dihydrofolate reductase	0	3	0	4
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	3	0	4
Thymidylate synthase	0	3	0	3
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Folate receptor beta	0	2	0	2
Cytochrome P450 11B1, mitochondrial	0	1	0	1
Folate receptor alpha	0	2	0	2
Dihydrofolate reductase	0	3	0	3
Histidine decarboxylase	0	1	2	3
Trifunctional purine biosynthetic protein adenosine-3	0	3	0	3
Bifunctional purine biosynthesis protein ATIC	0	5	0	5
Reduced folate transporter	0	3	0	3
Dihydrofolate reductase	0	1	0	1
Pteridine reductase 1	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	2	0	2
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Trifunctional purine biosynthetic protein adenosine-3	0	2	0	2
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Proton-coupled folate transporter	0	3	0	4
Cytochrome P450 2A13	0	2	2	4
Acidic phospholipase A2 2	0	1	0	1
Beta-2 adrenergic receptor	0	6	2	8
Beta-1 adrenergic receptor	0	4	2	7
Beta-1 adrenergic receptor	0	2	0	2
Chain A, PROGESTERONE RECEPTOR	0	1	0	1
Glucocorticoid receptor	0	1	0	1
Tegument protein VP16	0	0	1	1
Glucocorticoid receptor	0	1	1	2
Thyroid hormone receptor alpha	0	3	3	6
Thyroid hormone receptor beta	0	3	3	6
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Glucocorticoid receptor	0	1	0	1
Multidrug transporter MdfA	0	2	0	2
Leukotriene C4 synthase	0	1	0	1
Cysteinyl leukotriene receptor 1	0	1	0	1
Cysteinyl leukotriene receptor 2	0	1	0	1
Opioid receptor, delta 1b	0	1	0	1
Opioid receptor homologue	0	1	0	1
Acyl-CoA desaturase 1	0	1	0	1
Translocator protein	0	2	1	3
Kappa-type opioid receptor	0	4	1	7
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
UDP-glucuronosyltransferase 1A8	0	0	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	0	1	0	1
Hormone-sensitive lipase	0	1	0	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	2	2
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	2	2
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Atrial natriuretic peptide receptor 1	0	1	0	1
Neuropeptide Y receptor type 1	0	2	0	2
Neuropeptide Y receptor type 2	0	2	0	2
Nitric oxide synthase, endothelial	0	1	0	1
Cholesteryl ester transfer protein	0	2	0	2
D-amino-acid oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 3	0	0	1	1
Nicotinamidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	0	1	1
Hydroxycarboxylic acid receptor 2	0	3	1	4
D-aspartate oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	1	1	2
5-hydroxytryptamine receptor 3E	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
5-hydroxytryptamine receptor 3B	0	1	0	1
Acetylcholine receptor subunit alpha	0	3	1	4
Acetylcholine receptor subunit alpha	0	2	1	3
Acetylcholine receptor subunit beta	0	2	1	3
Acetylcholine receptor subunit gamma	0	2	1	3
Acetylcholine receptor subunit delta	0	2	1	3
Acetylcholine receptor subunit gamma	0	3	1	4
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta	0	3	1	4
Neuronal acetylcholine receptor subunit alpha-2	0	2	2	5
Neuronal acetylcholine receptor subunit beta-3	0	2	2	5
Neuronal acetylcholine receptor subunit alpha-5	0	2	2	5
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	1	1
Neuronal acetylcholine receptor subunit beta-4	0	3	1	4
Muscarinic acetylcholine receptor M4	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-3	0	3	1	4
Neuronal acetylcholine receptor subunit alpha-9	0	2	2	5
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
5-hydroxytryptamine receptor 3A	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-7	0	2	0	2
Acetylcholine-binding protein	0	1	1	2
Acetylcholine receptor subunit epsilon	0	0	1	1
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-7	0	2	2	5
Acetylcholine receptor subunit delta	0	3	1	4
Neuronal acetylcholine receptor subunit alpha-2	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
5-hydroxytryptamine receptor 3D	0	1	0	1
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
5-hydroxytryptamine receptor 3C	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-10	0	2	2	5
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	1	1	2
Glycoprotein IIb	0	1	1	2
tumor necrosis factor	2	0	0	2
Phospholipase A2, membrane associated	0	0	0	1
C-C chemokine receptor type 2	0	3	0	3
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
C-terminal-binding protein 1	1	0	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Sodium/iodide cotransporter	0	1	0	1
Cathepsin L2	0	2	0	2
Pro-cathepsin H	0	1	0	1
Dipeptidyl peptidase 1	0	1	0	1
Cathepsin Z	0	1	0	1
Cathepsin F	0	1	0	1
Phosphotyrosine protein phosphatase	0	1	0	1
Hemagglutinin [Cleaved into: Hemagglutinin HA1 chain; Hemagglutinin HA2 chain]	0	0	1	1
DNA polymerase beta	0	3	0	3
DNA polymerase beta	0	2	0	2
Receptor-type tyrosine-protein phosphatase alpha	0	2	0	2
Receptor-type tyrosine-protein phosphatase epsilon	0	2	0	2
Low molecular weight phosphotyrosine protein phosphatase	0	2	0	2
M-phase inducer phosphatase 2	0	3	0	3
Dual specificity protein phosphatase 3	0	1	0	1
Env polyprotein	0	0	2	2
Transmembrane prolyl 4-hydroxylase	0	1	2	3
Chain A, Adipocyte Lipid-binding Protein	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
putative potassium channel subunit	0	0	1	1
Sterol O-acyltransferase 1	0	2	0	2
Mcl-1	0	1	0	1
Bifunctional cytochrome P450/NADPH--P450 reductase	0	0	1	1
Potassium-transporting ATPase subunit beta	0	1	0	1
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Bombesin receptor subtype-3	0	0	1	1
Potassium-transporting ATPase alpha chain 2	0	0	0	1
Glutathione S-transferase omega-1	0	1	0	1
Phosphatidylserine lipase ABHD16A	0	1	0	1
Lipoprotein lipase	0	1	0	1
Hepatic triacylglycerol lipase	0	1	0	1
Pancreatic triacylglycerol lipase	0	1	0	1
Proteasome subunit beta type-1	0	1	0	1
Proteasome subunit beta type-2	0	1	0	1
Platelet-activating factor acetylhydrolase	0	3	0	4
Neutral cholesterol ester hydrolase 1	0	1	0	1
Diacylglycerol lipase-alpha	0	1	0	1
Lysophosphatidylserine lipase ABHD12	0	1	0	1
Diacylglycerol lipase-beta	0	1	0	1
Monoacylglycerol lipase ABHD6	0	1	0	1
Acyl-protein thioesterase 2	0	1	0	1
Diacylglycerol lipase-alpha	0	1	0	1
Endothelial lipase	0	1	0	1
Lysine-specific demethylase 6B	0	1	0	1
Kynurenine 3-monooxygenase	0	1	0	1
Lysine-specific demethylase 4A	0	1	0	1
Lysine-specific demethylase 5A	0	1	0	1
Lysine-specific demethylase 5C	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	2	0	2
Peptidyl-prolyl cis-trans isomerase A	0	1	0	1
Methylcytosine dioxygenase TET2	0	1	0	1
Lysine-specific demethylase 7A	0	1	0	1
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	0	1	0	1
Lysine-specific demethylase 5D	0	1	0	1
Lysine-specific demethylase 4C	0	1	0	1
Lysine-specific demethylase 5B	0	1	0	1
Histone lysine demethylase PHF8	0	1	0	1
Lysine-specific demethylase 2A	0	1	0	1
Lysine-specific demethylase 3A	0	1	0	1
MBT domain-containing protein 1	0	1	0	1
Lethal(3)malignant brain tumor-like protein 4	0	1	0	1
Lethal(3)malignant brain tumor-like protein 3	0	1	0	1
Lethal(3)malignant brain tumor-like protein 1	0	1	0	1
chaperonin GroEL	1	0	0	1
Alpha-1B adrenergic receptor	0	1	0	1
Alpha-2A adrenergic receptor	0	1	0	1
5-hydroxytryptamine receptor 1B	0	3	1	4
Vasopressin V1a receptor	0	1	0	1
Vasopressin V1b receptor	0	1	0	1
Oxytocin receptor	0	1	0	1
Vasopressin V2 receptor	0	1	0	1
Genome polyprotein	0	1	0	1
Integrin alpha-V	0	1	0	1
Botulinum neurotoxin type A	0	1	0	1
Cholecystokinin receptor type A	0	3	1	4
Melanocortin receptor 5	0	4	0	4
Bcl-2-like protein 1	0	3	0	3
Beta-tubulin	0	1	0	1
Chain A, Thymidylate Synthase	0	1	0	1
Chain A, Thymidylate Synthase	0	1	0	1
Chain A, Thymidylate Synthase	0	1	0	1
Serine hydroxymethyltransferase, cytosolic	0	1	1	2
Thymidylate synthase	0	1	0	1
Chain A, AMINOPEPTIDASE	0	1	0	1
Chain A, AMINOPEPTIDASE	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	2	0	2
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	2	0	2
Intestinal-type alkaline phosphatase	0	1	0	1
5'-nucleotidase	0	2	0	2
E3 ubiquitin-protein ligase XIAP	0	1	0	1
SLC16A10 protein	0	0	0	3
Large neutral amino acids transporter small subunit 1	0	1	0	1
Monocarboxylate transporter 10	0	0	0	3
Phospholipase A-2-activating protein	0	2	0	2
serine/threonine-protein kinase 33 isoform a	0	0	2	2
Monocarboxylate transporter 4	0	1	0	1
Beta-lactamase	0	3	0	3
Sodium/glucose cotransporter 1	0	2	0	2
Sodium/glucose cotransporter 2	0	1	0	1
Monocarboxylate transporter 1	0	2	0	2
Monocarboxylate transporter 2	0	2	0	2
Sodium/hydrogen exchanger 9B2	0	1	0	1
Chain D, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)	0	1	0	1
Chain A, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)	0	1	0	1
Chain A, Beta-arrestin 1	0	0	1	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	1	2
CDGSH iron-sulfur domain-containing protein 1	0	2	0	2
Peroxisome proliferator-activated receptor gamma	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	2	0	2
Carnitine O-palmitoyltransferase 2, mitochondrial	0	2	0	2
Carnitine O-palmitoyltransferase 1, liver isoform	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	2
CDGSH iron-sulfur domain-containing protein 2	0	2	0	2
Histamine H3 receptor	0	1	1	2
dual specificity mitogen-activated protein kinase kinase 1	1	0	0	1
RAF proto-oncogene serine/threonine-protein kinase isoform b	1	0	0	1
Dihydrolipoyl dehydrogenase, mitochondrial	0	0	0	1
M-phase inducer phosphatase 1	0	2	0	2
Mitogen-activated protein kinase kinase kinase 14	0	1	0	1
luciferase	0	0	0	1
Glutamine synthetase	0	0	1	1
Nociceptin receptor	0	0	1	1
Glutamate 5-kinase	0	0	0	1
Chloroquine resistance transporter	0	1	0	1
Beta-2 adrenergic receptor	0	2	0	3
Beta-3 adrenergic receptor	0	2	0	2
Neuromedin-K receptor	0	0	1	1
Beta-2 adrenergic receptor	0	1	0	1
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
Chain A, dATP pyrophosphohydrolase	0	1	0	1
Chain A, Adenylate cyclase type 5	0	1	0	1
Chain B, Adenylate cyclase type 2	0	1	0	1
Chain A, APH(2')-Id	0	1	0	1
glucose-6-phosphate dehydrogenase	0	1	0	1
DNA polymerase III, partial	3	0	0	3
hexokinase	0	1	0	1
B2 bradykinin receptor	0	1	0	1
Prothrombin	0	1	0	1
Chymotrypsin-like elastase family member 1	0	1	0	1
Protein E6	0	1	0	1
Epoxide hydrolase 1	0	1	0	1
Heterogeneous nuclear ribonucleoprotein A1	0	0	1	1
Malate dehydrogenase	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 2	0	1	0	1
Chymotrypsinogen B	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
C-X-C chemokine receptor type 1	0	1	0	1
Glutathione reductase	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	2	0	2
C-C chemokine receptor type 4	0	1	0	1
Oligo-1,6-glucosidase IMA1	0	1	0	1
Aldo-keto reductase family 1 member B1	0	1	0	1
Heat shock factor protein 1	0	1	0	1
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	3	0	3
ELAV-like protein 3	0	1	0	1
ELAV-like protein 1	0	1	0	1
Probable maltase-glucoamylase 2	0	1	0	1
Aldo-keto reductase family 1 member C21	0	3	0	3
Chymotrypsin-C	0	1	0	1
Prolyl 4-hydroxylase, beta polypeptide	0	0	0	2
Non-structural protein 1	0	1	0	1
Histone deacetylase 8	0	1	1	2
NAD-dependent protein deacetylase sirtuin-2	0	2	1	3
NAD-dependent protein deacetylase sirtuin-1	0	1	1	4
NAD-dependent protein deacetylase sirtuin-7	0	1	0	1
NAD-dependent protein deacetylase sirtuin-3, mitochondrial	0	1	1	2
Nuclear receptor corepressor 2	0	1	0	1
Insulin-degrading enzyme	0	1	0	1
NAD(+) hydrolase SARM1	0	1	0	1
Phospholipase D2	0	1	0	1
Aldehyde oxidase 1	0	1	0	1
Complement C5	0	0	1	1
Phospholipase D1	0	2	0	2
Aldehyde oxidase 1	0	1	0	1
Phospholipase D1	0	2	1	3
Aldehyde oxidase 1	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	1	1
Gastric inhibitory polypeptide receptor	0	1	0	1
Cathepsin K	0	1	0	1
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
M18 aspartyl aminopeptidase	0	1	0	1
cathepsin L1	0	1	0	1
Vif	0	1	0	1
Aryl hydrocarbon receptor	0	1	0	1
Myc proto-oncogene protein	0	1	0	2
Luciferin 4-monooxygenase	0	1	1	2
DNA polymerase alpha catalytic subunit	0	1	0	1
Endothelin receptor type B	1	0	0	1
Endothelin-1 receptor	1	0	0	1
Cannabinoid receptor 1	0	4	1	5
N1L	0	1	0	1
Lysosomal alpha-glucosidase	0	1	0	1
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR	0	0	1	1
Retinol-binding protein 4	0	0	1	1
Beta-lactoglobulin	0	0	1	1
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase	0	0	1	1
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase	0	0	1	1
Chain H, Immunoglobulin Igg1 Heavy chain	0	0	1	1
Chain L, Immunoglobulin Igg1 Lambda Light Chain	0	0	1	1
Chain A, DODECIN	0	0	1	1
Chain A, DODECIN	0	0	1	1
Chain C, DODECIN	0	0	1	1
Chain E, DODECIN	0	0	1	1
Butyrophilin subfamily 3 member A1	0	0	2	3
4-hydroxy-3-methylbut-2-enyl diphosphate reductase	0	1	0	1
Farnesyl diphosphate synthase	0	1	0	1
H	0	2	0	2
Phosphotransferase	0	1	0	1
Farnesyl diphosphate synthase	0	1	0	1
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, POL polyprotein	0	1	0	1
Chain B, POL polyprotein	0	1	0	1
Chain A, POL polyprotein	0	1	0	1
Chain B, POL polyprotein	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Thromboxane-A synthase	0	0	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	1	0	1
Retina-specific copper amine oxidase	0	2	0	2
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	2	0	2
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	0	1	0	1
Tumor necrosis factor	0	1	1	2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	3	0	4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	3	0	4
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	3	0	5
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	3	0	4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	3	0	3
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	1	0	1
cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
Endothelin-1 receptor	0	1	0	1
Phosphodiesterase	0	1	0	1
Protein cereblon	0	2	0	2
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	0	2	0	2
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	0	1	0	1
Phosphodiesterase	0	2	0	2
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	2	0	2
Extracellular calcium-sensing receptor	0	1	0	1
Catechol O-methyltransferase	0	0	1	1
ATP-binding cassette sub-family C member 8	0	1	0	1
ATP-sensitive inward rectifier potassium channel 11	0	1	0	1
Thrombin	0	0	1	1
L-lactate dehydrogenase A chain	0	1	0	1
Neuromedin-U receptor 2	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, 146aa long hypothetical transcriptional regulator	0	0	1	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain B, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain C, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Anthranilate phosphoribosyltransferase	0	1	0	1
5'-AMP-activated protein kinase subunit beta-2	0	0	0	1
Polymerase acidic protein	0	0	1	1
Tyrosine-protein phosphatase YopH	0	1	0	1
Cystathionine gamma-lyase	0	1	0	1
Ubiquitin-like domain-containing CTD phosphatase 1	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-3	0	0	0	1
5'-AMP-activated protein kinase subunit beta-1	0	0	0	1
Chain E, Fibrin beta chain	0	1	0	1
phospholipase A2, group III	0	1	0	1
Alanine aminotransferase 1	0	0	0	2
Bcl2-associated agonist of cell death	0	1	0	1
Single-stranded DNA cytosine deaminase	1	0	0	1
Regulator of G-protein signaling 17	0	1	1	2
Chain A, Proto-oncogene tyrosine-protein kinase Src	0	1	0	1
Nucleoside diphosphate kinase B	0	0	1	1
Programmed cell death protein 1	0	1	0	1
Programmed cell death 1 ligand 1	0	1	0	1
Sterol O-acyltransferase 2	0	1	0	1
Tyrosine-protein phosphatase 1	0	1	0	1
Pyruvate kinase PKLR	0	1	0	1
Neuraminidase	0	1	0	1
Class A sortase SrtA	0	1	0	1
photoreceptor-specific nuclear receptor	0	1	0	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	1	0	1
Eukaryotic translation initiation factor 4E	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP1B	0	0	2	2
Peptidyl-prolyl cis-trans isomerase FKBP5	0	2	0	2
Programmed cell death protein 4	0	0	1	1
Serine/threonine-protein kinase mTOR	0	1	0	1
Carbonic anhydrase	0	1	0	1
C-X-C chemokine receptor type 5 isoform 1	0	1	0	1
C-C chemokine receptor type 6	0	1	0	1
apelin receptor	0	1	0	1
Endoglycoceramidase II	0	0	0	1
Protein kinase C alpha type	0	2	0	2
Protein kinase C delta type	0	2	0	2
Protein kinase C epsilon type	0	2	0	2
Protein kinase C zeta type	0	2	0	2
cAMP-dependent protein kinase catalytic subunit alpha	0	1	0	1
Protein kinase C gamma type	0	2	0	2
Protein kinase C beta type	0	2	0	2
Protein kinase C eta type	0	2	0	2
Sphingosine kinase 2	0	1	0	1
Sphingosine kinase 1	0	1	0	1
Protein kinase C theta type	0	2	0	2
Sphingosine 1-phosphate receptor 2	0	1	1	2
Sphingosine 1-phosphate receptor 4	0	1	1	2
Sphingosine 1-phosphate receptor 1	0	1	1	2
Sphingosine 1-phosphate receptor 3	0	1	1	2
Sphingosine 1-phosphate receptor 5	0	1	1	2
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Orexin receptor type 1	0	0	0	1
Fatty acid-binding protein, liver	0	1	0	1
N-arachidonyl glycine receptor	0	1	0	1
G-protein coupled receptor 55	0	0	1	1
Chain A, Ribosomal protein S6 kinase alpha-1	0	1	0	1
Chain X, Tyrosine-protein kinase Lyn	0	1	0	1
Chain A, Dual specificity protein kinase TTK	0	0	1	1
Chain A, Dual specificity protein kinase TTK	0	0	1	1
Substance-P receptor	0	2	0	2
Neuromedin-K receptor	0	0	1	1
Substance-K receptor	0	1	1	2
Substance-P receptor	0	4	1	5
Neuromedin-K receptor	0	1	1	2
Substance-K receptor	0	1	0	1
Substance-K receptor	0	1	0	1
Growth hormone secretagogue receptor type 1	0	0	1	1
Delta-aminolevulinic acid dehydratase	0	1	0	1
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	1	0	1
NADP-dependent malic enzyme, mitochondrial	0	0	0	1
Solute carrier family 13 member 3	0	1	0	1
Methyl-accepting chemotaxis protein NahY	0	0	1	1
Chain A, Glutathione S-transferase	0	1	0	1
Fibroblast growth factor 1	0	0	1	1
Cystine/glutamate transporter	0	1	0	1
Carbonic anhydrase	0	0	0	2
Carbonic anhydrase	0	1	0	1
D(2) dopamine receptor	0	1	0	1
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	0	2	0	2
Splicing factor 3B subunit 3	0	1	0	1
Chain A, CES1 protein	0	1	0	1
Lysosomal acid glucosylceramidase	0	0	1	1
Protein kinase C gamma type	0	2	1	3
Transcriptional activator protein LuxR	0	1	0	1
B2 bradykinin receptor	0	2	0	2
Melanocortin receptor 4	0	2	0	2
Melanocortin receptor 3	0	2	0	2
Emopamil-binding protein-like	0	1	0	1
7-dehydrocholesterol reductase	0	1	1	2
RAD51	0	1	0	1
Polycomb protein EED	0	1	0	1
Glycoprotein hormones alpha chain	1	0	0	1
Polycomb protein SUZ12	0	1	0	1
Histone-lysine N-methyltransferase EZH2	0	1	0	1
Chain A, Prostatic Acid Phosphatase	0	1	0	1
Sodium- and chloride-dependent taurine transporter	0	1	0	1
Sodium/bile acid cotransporter	0	0	0	1
Ileal sodium/bile acid cotransporter	0	0	0	1
Ileal sodium/bile acid cotransporter	0	0	0	1
Solute carrier organic anion transporter family member 4A1	0	0	0	2
Solute carrier organic anion transporter family member 2B1	0	0	0	1
Bile salt export pump	0	0	0	1
Thromboxane A2 receptor	0	0	0	2
Peroxisome proliferator-activated receptor delta	0	0	1	1
90-kda heat shock protein beta HSP90 beta, partial	0	2	0	2
estrogen receptor beta isoform 1	0	1	0	1
tyrosine-protein phosphatase non-receptor type 7 isoform 2	0	1	0	1
Dihydroxyacetone phosphate acyltransferase	0	0	0	1
30S ribosomal protein S6	0	1	0	1
30S ribosomal protein S7	0	1	0	1
50S ribosomal protein L15	0	1	0	1
Tetracycline resistance protein, class B	0	0	0	1
50S ribosomal protein L10	0	1	0	1
50S ribosomal protein L11	0	1	0	1
50S ribosomal protein L7/L12	0	1	0	1
50S ribosomal protein L19	0	1	0	1
50S ribosomal protein L1	0	1	0	1
50S ribosomal protein L20	0	1	0	1
50S ribosomal protein L27	0	1	0	1
50S ribosomal protein L28	0	1	0	1
50S ribosomal protein L29	0	1	0	1
50S ribosomal protein L31	0	1	0	1
50S ribosomal protein L31 type B	0	1	0	1
50S ribosomal protein L32	0	1	0	1
50S ribosomal protein L33	0	1	0	1
50S ribosomal protein L34	0	1	0	1
50S ribosomal protein L35	0	1	0	1
50S ribosomal protein L36	0	1	0	1
30S ribosomal protein S10	0	1	0	1
30S ribosomal protein S11	0	1	0	1
30S ribosomal protein S12	0	1	0	1
30S ribosomal protein S13	0	1	0	1
30S ribosomal protein S16	0	1	0	1
30S ribosomal protein S18	0	1	0	1
30S ribosomal protein S19	0	1	0	1
30S ribosomal protein S20	0	1	0	1
30S ribosomal protein S2	0	1	0	1
30S ribosomal protein S3	0	1	0	1
30S ribosomal protein S4	0	1	0	1
30S ribosomal protein S5	0	1	0	1
30S ribosomal protein S8	0	1	0	1
30S ribosomal protein S9	0	1	0	1
50S ribosomal protein L13	0	1	0	1
50S ribosomal protein L14	0	1	0	1
50S ribosomal protein L16	0	1	0	1
50S ribosomal protein L23	0	1	0	1
30S ribosomal protein S15	0	1	0	1
50S ribosomal protein L17	0	1	0	1
50S ribosomal protein L21	0	1	0	1
50S ribosomal protein L30	0	1	0	1
50S ribosomal protein L6	0	1	0	1
30S ribosomal protein S14	0	1	0	1
30S ribosomal protein S17	0	1	0	1
30S ribosomal protein S1	0	1	0	1
50S ribosomal protein L18	0	1	0	1
Neutrophil collagenase	0	3	0	3
50S ribosomal protein L2	0	1	0	1
50S ribosomal protein L3	0	1	0	1
50S ribosomal protein L24	0	1	0	1
50S ribosomal protein L4	0	1	0	1
50S ribosomal protein L22	0	1	0	1
50S ribosomal protein L5	0	1	0	1
30S ribosomal protein S21	0	1	0	1
50S ribosomal protein L25	0	1	0	1
50S ribosomal protein L36 2	0	1	0	1
P2Y purinoceptor 12	0	1	0	1
Ras guanyl-releasing protein 3	0	0	1	1
Thymidine kinase	0	1	0	2
Thymidine kinase	0	1	0	2
Thymidine phosphorylase	0	0	0	1
Thymidylate kinase	0	1	0	1
Thymidine kinase, cytosolic	0	0	0	2
Thymidine kinase	0	0	0	1
Thymidylate kinase	0	1	0	1
Thymidine kinase	0	1	0	2
Thymidine kinase	0	0	0	1
Thymidine kinase	0	0	0	1
Thymidine phosphorylase	0	1	0	1
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Proliferating cell nuclear antigen	0	2	0	2
Malate dehydrogenase, mitochondrial	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	1	0	2
Monocarboxylate transporter 8	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
Matrix metalloproteinase-14	0	2	0	2
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with trehalose	0	1	0	1
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with cellobiose	0	1	0	1
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with maltose	0	1	0	1
Trehalose-phosphatase	0	1	0	1
Chain A, Nuclear Receptor ROR-beta	0	1	0	1
Ornithine decarboxylase	0	0	0	1
Retinoic acid receptor alpha	0	2	2	7
Retinoic acid receptor beta	0	2	2	7
Retinoic acid receptor alpha	0	1	2	3
Retinoic acid receptor gamma	0	2	2	7
Retinoic acid receptor gamma	0	1	2	3
Retinoic acid receptor beta	0	1	2	3
Cellular retinoic acid-binding protein 2	0	0	1	1
Retinoic acid receptor RXR-alpha	0	1	2	3
Retinoic acid receptor RXR-beta	0	2	2	4
Retinoic acid receptor RXR-beta	0	1	2	3
Retinoic acid receptor RXR-gamma	0	1	2	3
Nuclear receptor ROR-alpha	0	1	0	1
Cellular retinoic acid-binding protein 1	0	1	0	2
Retinoic acid receptor RXR-gamma	0	2	2	4
Cellular retinoic acid-binding protein 1	0	0	1	1
Nuclear receptor ROR-beta	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, Repressor	0	0	1	1
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
twin arginine protein translocation system - TatA protein	0	0	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	1
Endoplasmic reticulum chaperone BiP	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI	0	2	0	2
Enoyl-acyl carrier reductase	0	1	0	1
Enoyl-ACP reductase II	0	1	0	1
Diamine acetyltransferase 1	0	0	0	1
Thialysine N-epsilon-acetyltransferase	0	0	0	1
Thyroid hormone receptor beta	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	0	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
Tubulin--tyrosine ligase	0	1	0	1
Taste receptor type 2 member 14	0	0	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
Basic phospholipase A2 1	0	1	0	1
Hemagglutinin	0	0	1	1
Basic phospholipase A2 PLA-A	0	1	0	1
Acidic phospholipase A2 EC-I	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase 7	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase 47	0	1	0	1
Sentrin-specific protease 1	0	1	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
Cytochrome c oxidase subunit 1	0	1	0	1
Carbonic anhydrase	0	1	0	1
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
Platelet glycoprotein VI	0	0	1	1
D-alanyl-D-alanine dipeptidase	0	1	0	1
Sterol 14-alpha-demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
Cholesterol side-chain cleavage enzyme, mitochondrial	0	0	1	1
Lanosterol 14-alpha demethylase	0	0	1	1
Cytochrome P450 144	0	0	1	1
Steroid C26-monooxygenase	0	0	1	1
Steroid C26-monooxygenase	0	0	1	1
Sterol 14-alpha demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
Cholesterol 24-hydroxylase	0	2	1	3
Proprotein convertase subtilisin/kexin type 7	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
Farnesyl diphosphate synthase	0	2	0	2
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	0	1	0	1
cGMP-specific 3',5'-cyclic phosphodiesterase	0	0	1	1
cGMP-specific 3',5'-cyclic phosphodiesterase	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Alkaline phosphatase, germ cell type	0	1	0	1
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	0	1	0	1
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	0	1	0	1
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	0	1	0	1
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
G protein-coupled receptor GPR35	0	0	1	1
G-protein coupled receptor 35	0	0	1	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Synonyms(6)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (6,005)

Protein Targets (2,973)

Bone Loss, Perimenopausal

Synonyms(6)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (6,005)

Drugs Studied (736)

Protein Targets (2,973)